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Executive Summary
An interconnected network of accredited federal, state, local, tribal, and territorial laboratories
is critical to ensuring the safety of the U.S. food supply and the development of the Integrated
Food Safety System (IFSS). In 2004, as part of a national policy to defend the U.S. food supply
against terrorist attacks, major disasters, and other emergencies, the Food Emergency
Response Network (FERN) was created to integrate the nation’s multilevel (i.e., federal, state,
local, tribal, territorial) food-testing laboratories to detect, identify, respond to, and recover
from a bioterrorism act affecting the safety of the food supply, or a public health
emergency/outbreak involving the food supply. Since 2004, federal agencies have invested an
estimated $200 million in FERN. The majority of this investment has been in the FERN
cooperative agreements with FDA and USDA-FSIS investing $95.8 million and $69 million,
respectively. FDA has promoted the accreditation of state laboratories through cooperative
agreement funding, investing more than $50 million to fund these grants.
On November 11, 2014, the Office of Regulatory Affairs (ORA) requested that the FDA Science
Board establish a subcommittee to evaluate current investments in: (1) the FERN cooperative
agreement funding program (CAP), and (2) funding for state laboratories to achieve
International Organization for Standardization (ISO) accreditation. The goal was to ascertain
how ORA can advance and establish an effective integrated laboratory network among ORA,
FDA Center, and state public health and food- and feed-testing laboratories. In response to this
request, the Science Board created the ORA FERN Cooperative Agreement Evaluation
Subcommittee on July 1, 2015. This report summarizes the results of the Subcommittee’s
review.
The Subcommittee found that FERN plays a critical role in establishing a national, integrated
food safety system and has had a significant public health impact. FERN is instrumental in
increasing national capability and capacity to detect, prevent, prepare for, respond to, and
recover from threats to our country’s food supply. FERN has successfully promoted integration
of regulatory functions and emergency response preparedness in laboratories across the
nation; however, with nearly 170 laboratories among the FDA, CDC, USDA-FSIS, and states,
there are many more laboratories than FDA and USDA-FSIS have funds to support. Therefore, it
is important for FDA (and consequently USDA-FSIS) to critically evaluate how FERN’s limited
funds can best be utilized to build a sustainable integrated laboratory network that meets
public health and regulatory needs within an integrated national food safety system.
FDA’s commitment to provide future funding opportunities to FERN will be required to sustain
and ensure the realization of a fully integrated multilevel (e.g., federal, state, local) food-testing
laboratory network. Such future funding increases should be to increase the depth and breadth
of the program, meaning both further increases to the capacity of existing laboratories as well
as expanding the numbers of laboratories receiving FERN support. Further, it is important that
FDA modernize its food safety information architecture to ensure safe and secure transmission
of data even while encouraging and facilitating efficient data sharing and collaboration across
the entire network of food safety regulatory laboratories. Investments in FERN should save
1

money in terms of reduced public health costs as well as costs to industry, but metrics are
needed to more directly assess public health impacts, functionality of the network as a system,
as well as other goals, such as efficiency. Importantly, FDA has the opportunity, in collaboration
with USDA-FSIS, to continue to develop and expand the FERN network. Specifically, the
Subcommittee makes the following recommendations:
1. FERN consists of a group of diverse laboratories, and the focus on developing a basic level
of capability/capacity across the network is a worthwhile goal that should be supported by
the federal government. The baseline capabilities/capacities needed are not static and
funding should be adapted to reflect these changing needs.
2. Efforts to build and sustain capabilities/capacities across FERN need consistent, multi-year
funding. FDA should consider additional sources of funding, including cost-sharing or
matching requirements for grant programs and recipients, where appropriate and/or
possible.
3. While all laboratories should strive to improve capabilities, especially as some techniques
become more routine, FDA should develop a plan for FERN that would consider the
advantages of a tiered approach designed to avoid unnecessary duplication, for example, of
expensive instrumentation across the network. Thus, while all laboratories should share a
basic level of functionality, the advanced performance capabilities could be housed
primarily or exclusively in regional/national facilities and/or centers to promote efficient
use of existing expertise, equipment, and technical resources.
4. FERN funding agencies (i.e., FDA/ORA, USDA-FSIS) should continue to improve their
engagement with the CDC/LPRB-LRN Program Office to discuss areas of common interest
and combine efforts to improve testing capacity and capability within and across networks.
5. FDA should develop a technology-management plan to anticipate the eventual replacement
of existing instrument platforms that employ newer and more advanced diagnostic
methodologies. The plan should be developed in collaboration with the Centers of
Excellence and include: platform selection, acquisition, upgrades/enhancements, along with
corresponding technical training for personnel.
6. FDA should assume a holistic approach to addressing the IT and data-sharing needs of FERN
partners. There is a strong public health need for an integrated information infrastructure
that allows the seamless transmission of data in a secure environment that facilitates rapid
analytics. Simply trying to fix the current system is unlikely to achieve this goal; a new
system is needed. Such efforts must be guided by a comprehensive plan that is developed
through stakeholder engagement (i.e., cooperative agreement laboratories) to meet the
needs of an integrated food and feed safety system.
7. FERN leadership should develop clear objectives and adopt a set of metrics for both
individual laboratories and the network, with appropriate targets and consensus as to what
constitutes success and reflects the objectives.
2

8. FDA, in collaboration with other federal agencies, should convene an annual conference for
the food safety laboratory network to engage scientists in professional
education/development activities and facilitate the sharing of information.
9. FERN should have the capacity to support professional travel to conferences and/or for
training and development.
10. FDA and its sister federal agencies (i.e., USDA-FSIS, CDC) should work with states on best
practices for hiring and retaining scientists who are needed to perform this mission-critical
work. Possible collaborators for initiating such efforts include the National Governor’s
Association and/or National Conference on State Legislatures. These organizations may be
able to assist with the identification and/or development of models that can be considered
for adoption by states nationally.
11. FDA should regularly communicate with all eligible laboratories to increase public health
preparedness and participation in FERN training efforts.
The Subcommittee advises that the recommendations of this report be accepted with the
utmost urgency and that our specific recommendations be considered as a means of ensuring
the maintenance of a safe and secure food system. The FERN network represents one of the
best national investments in improving the responsiveness of our combined federal, state, local
and territorial governments; the development of IFSS; and the prevention of foodborne
disease.

3

1. Introduction
Foodborne diseases are a significant public health issue in the United States, causing an
estimated 48 million illnesses, 125,000 hospitalizations, and 3,000 deaths annually, according to
the Centers for Disease Control (CDC).1,2,3 The U.S. food system is complex, and managing risks
throughout the supply chain is a challenging task that requires an integrated, risk-based
approach. Recognizing this, Congress enacted the Food Safety Modernization Act (FSMA) in
January 2011, providing the first major overhaul of food safety oversight at the U.S. Food and
Drug Administration (FDA), which oversees the safety of approximately 80% of the food supply,
in nearly 70 years.4
FSMA directs FDA to build, in partnership with other federal, state, local, tribal, and territorial
food safety agencies, an Integrated Food Safety System (IFSS) that is focused on prevention and
enhanced collaboration across these safety agencies.5 Specifically, FSMA directs FDA to develop
and implement strategies to leverage and enhance food safety and defense capacities of state
and local agencies, including establishing a program for the testing of food by accredited
laboratories6 and the Integrated Consortium of Laboratory Networks (ICLN).7
An interconnected network of high-quality federal, state, local, tribal, and territorial
laboratories is critical to ensuring the safety of the food supply and the development of IFSS. In
2004, as part of a national policy to defend the food supply against terrorist attacks, major
disasters, and other emergencies, Homeland Security Presidential Directive 9 (HSPD-9) required
the development of nationwide laboratory networks for food, veterinary, plant health, and
water quality (e.g., FERN, Vet-LIRN, NAHLN, EPA) that: (1) integrate existing federal- and stategovernment laboratory resources, (2) are interconnected, and (3) utilize standardized
diagnostic protocols and procedures.8
In response to HSPD-9, the Food Emergency Response Network (FERN) was created to integrate
the nation’s multilevel (i.e., federal, state, local, tribal, territorial) food-testing laboratories to
detect, identify, respond to, and recover from a bioterrorism act or public health
emergency/outbreak involving the food supply. FERN has four main objectives:
1) Prevent attacks on the nation’s food supply by providing means for early detection of
threat agents;
2) Prepare member laboratories (i.e., federal, state, local, tribal, territorial) to respond to
food-related emergencies;
1

http://www.cdc.gov/foodborneburden/2011-foodborne-estimates.html
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, et al. 2011 (Jan.). Foodborne Illness Acquired in the
United States—Major Pathogens. Emerging Infectious Diseases, 17(1):7–15.
3 Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. Foodborne Illness Acquired in the United States—Unspecified Agents.
Emerging Infectious Diseases, 17(1):16–22.
4 http://www.fda.gov/Food/GuidanceRegulation/FSMA/default.htm
5 FSMA Act – Section 209
6 FSMA Act – Section 202
7 FSMA Act – Section 203
8 Homeland Security Presidential Directive/HSPD-9. 2004 (Jan. 30), http://fas.org/irp/offdocs/nspd/hspd-9.html
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3) Provide and coordinate regional and national surge capacity for laboratories;
4) Assist in recovery efforts to restore confidence in the food supply following a threat or
actual emergency.
FERN, which is coordinated by the U.S. Food and Drug Administration (FDA) and the U.S.
Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS), provides multiple
areas of support to member laboratories, including cooperative agreement funding. Currently,
there are 170 member laboratories in FERN, and through cooperative agreements, FDA funds
33 state laboratories; the latter include 13 chemistry laboratories, 15 microbiology laboratories,
and 5 radiology laboratories. These laboratories are intended to provide increased capability
and capacity for conducting sample analyses of food products for the rapid detection and
identification of large-scale food contaminations, intentional or accidental, and have provided
these functions for the FDA in most of the large-scale national food events since their initial
funding. According to FDA, approximately $95.8 million has been awarded to state, local, tribal,
and territorial laboratories since 2005, and an estimated $500,000 is spent internally each year
to support FERN activities.
On November 11, 2014, the Office of Regulatory Affairs (ORA) requested that the FDA Science
Board establish a new subcommittee to evaluate the current investments in: (1) the FERN
cooperative agreement program, and (2) funding for state laboratories to achieve International
Organization for Standardization (ISO) accreditation.9 The goal was to ascertain how ORA can
advance and establish an effective integrated laboratory network among ORA, FDA Centers,
and state public-health and food- and feed-testing laboratories. In response to this request, the
ORA FERN Cooperative Agreement Evaluation Subcommittee of the Science Board to the Food
and Drug Administration (Subcommittee) was established on July 1, 2015 (Appendix A).

2. Charge to the FERN Cooperative Agreement Evaluation Subcommittee
The scope of work for this Subcommittee includes evaluation of three existing FDA state
cooperative agreement program (CAP) grants to enhance FERN laboratory capability/capacity,
help laboratories attain accreditation, and integrate the food safety community, and to assess
how these agreements or other approaches can best be utilized to build an integrated
laboratory network among public health and food- and feed-testing laboratories.
Specifically, the question to the Subcommittee is how can the Agency continue to build a
sustainable, integrated, and mutually reliant laboratory network that meets the public health
and regulatory needs under an integrated national food safety system? Integrated refers to the
combining of both regulatory and emergency response functions within each laboratory, and
mutually reliant refers to the capacity and capability of laboratories — be they state, CDC, FDA,

9

http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/ScienceBoardtotheFoodandDrugAdministration/ucm4
23187.htm
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USDA-FSIS, or food- and feed-testing laboratories — to be able to rely on each other to provide
testing and regulatory data and analyses that are reliable in their respective functions.
The Subcommittee’s scope of work also includes an assessment of the technical areas of data
quality and sharing, proficiency testing, method harmonization, and analytical results reporting
sufficient to allow recommendations that could facilitate the rapid and efficient interchange of
laboratory results in an integrated laboratory network.
Questions from ORA for the Board’s FERN Subcommittee to Address:
1) How can we further promote and build an integrated laboratory network among the
food regulatory laboratories of ORA, FDA Centers, USDA’s FSIS, and state health
departments as part of developing a stronger system of mutual reliance in the food and
feed program?
2) What are the appropriate scientific, analytical and technical capabilities required to
facilitate the sharing of laboratory data between public health and regulatory agencies
in a timely and efficient manner to enhance consumer protection?
3) What are the realized benefits and limitations to these FERN Network, laboratory
accreditation, and Laboratory Associations (e.g., APHL, AFDO, AAFCO) cooperative
agreements, and how can we improve upon the current utilization of the results of
these agreements?
4) How impactful to public health has this building of an integrated laboratory network and
promotion of our state laboratories been to date? Explore case studies.
5) What would be appropriate metrics to measure the effectiveness of these integration
strategies in promoting a national integrated laboratory system?

3. Evaluation Process
The evaluation process used by the FERN Subcommittee consisted of a review of background
materials; meetings and discussions with FDA, staff from state and local laboratories, and
others; and a site visit. The Subcommittee met regularly via conference call to review
documents and conduct interviews.
The Subcommittee was provided with background documentation on FERN by the FDA-ORA
Office of Partnership and the FERN National Program Office. The Subcommittee was provided
with the latest available progress reports covering the performance dates from September 1,
2015, through February 29, 2016, from 24 randomly selected laboratories provided by the FDA.
Ten reports represented FERN/CAP-funded laboratories; another ten reports represented the
ISO/IEC laboratories; while five reports represented ISO/IEC self-assessment gap-analysis.
Budget plans from five state public health or agriculture laboratories that were awarded funds
for both chemical and microbiology preparedness areas were evaluated for consistency of
expenditures relative to expected outcomes. Additionally, the Subcommittee reviewed an
interim progress report, dated March 30, 2016, from the Association of Public Health
Laboratories (APHL) for a cooperative agreement for “Building an Integrated Laboratory System
6

to Advance the Safety of Food and Animal Feed.” Finally, the Subcommittee reviewed detailed
budget information from FY15.
The Subcommittee also invited FERN-relevant presentations by FDA and other organizations
and conducted several interviews with management and leadership staff at laboratories in five
non-funded states, including Florida, Indiana, New York, Pennsylvania, and Utah during
separate teleconferences in February and March 2016. Presenters and interviewees, along with
their institutional affiliations, are listed in Appendix B; questions drafted by the Committee are
provided in Appendix C.
To further inform its review with real-world data and information, the Subcommittee
conducted a site visit in Richmond, Virginia, at the Division of Consolidated Laboratory Services
(DCLS) on January 12, 2016. This FDA CAP laboratory was chosen for a site visit in part because
it is generally regarded as a well-functioning, full-service laboratory, exemplary by virtue of its
efficient, integrated, collaborative, and productive operations that are highly valued by FERN.
The Richmond laboratory serves as a prime example of how federal resources could be, for
example, leveraged in order to inform and train personnel from other facilities, tapped as a
source of best practices, and modeled by other laboratories. Also, the Richmond laboratory is
funded through cooperative agreements by both FDA and USDA-FSIS for chemical and
microbiological analyses. In addition, USDA-FSIS, through its CAP, supports DCLS as a training
center for other FERN laboratories.
To produce the present report, the Subcommittee chair assigned individual Subcommittee
members to compose first drafts of various chapters (i.e., Funding, Metrics, Data Analytics,
Training and Development, and Impact on Public Health). The chair consolidated the drafts and
compiled the final report with the assistance of a technical writer-editor.

4. Overview of FERN
FERN’s mission is to integrate the nation’s food testing laboratories at the federal, state, and
local and tribal levels into a network that is able to respond to emergencies involving biological,
chemical, or radiological contamination of food. FERN’s objectives are to provide for an early
means of detecting threat agents in the U.S. food supply; prepare the nation’s laboratories to
be capable of responding to food-related emergency events; provide surge capacity that will
allow the nation to respond to food emergency events; and enhance the ability of the country
to restore confidence in the food supply after an emergency or in response to a threat. FERN
achieves its objectives by conducting laboratory testing and targeted surveillance programs;
developing standardized food testing methodologies; providing chemical, microbiological, and
radiological training activities; conducting proficiency testing; and facilitating communication
among member laboratories.
Federal, state, local, tribal, and territorial government food-testing laboratories that have
chemical, biological, and/or radiological analytical capabilities can apply to become a member
of FERN. As stated previously, there are currently 170 member laboratories in FERN, including
7

public health, agriculture, environmental, and veterinary diagnostic laboratories. Individual
laboratories are categorized based on laboratory capability responses posted on the FERN
website Laboratory Directory (LabDIR). Each laboratory has separate tabulations for each
discipline registered, as well as one overall number obtained by totaling all of the disciplines
registered for in LabDIR, and this is combined with the responses to the general laboratory
questions for an overall result. Each laboratory’s total discipline-specific and overall scores
determine the laboratory’s category. This tiering process facilitates the laboratory selection
process for a FERN activation event. The categorization serves as a tool for FERN to view the
capabilities of its member laboratories in real time and can be used as any other tool in the
National Program Office/Regional Coordination Center tool belt, but is not an official
requirement in the process of “activation” of FERN in responding to an emergency event. The
individual assessment of laboratory capability/capacity in the FERN regions is done by the
regional coordinators, in coordination with the National Program Office, in response to specific
emergency events as part of the official “activation” of FERN. Several federal agencies are FERN
partners, including FDA, USDA-FSIS, CDC, DOD, FBI, EPA, DHS, and DOE.10 The organizational
structure of FERN is shown in Figure 1.

Figure 1. FERN Organizational Structure. From: Biennial Report to Congress on the Food Emergency Response
Network. 2013 (Nov.). Food and Drug Administration.

Funds have been invested in FERN by both FDA and USDA-FSIS to enhance laboratory
capacity/capability and by FDA to assist state laboratories in attaining laboratory accreditation
10

Frequently used abbreviations and acronyms are defined in the Abbreviations and Acronyms section at the beginning of this
report.
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in accordance with ISO International Electrotechnical Commission (i.e., ISO/IEC 17025:2005).
ISO is an independent, non-governmental organization made up of members from the national
standards bodies of 162 countries (http://www.iso.org). Accreditation by ISO is seen by many as
a gold standard for establishing national laboratory standards and implementing a fully
integrated national food safety system with mutually acceptable analytical data. Forty-six state
FERN laboratories are currently being funded by the ISO/IEC 17025:2005 Cooperative
Agreement. In 2015, findings of the food samples by these FDA/FERN-ISO-supported
laboratories triggered two nationwide recalls of ice cream products for L. monocytogenes
contamination.
In addition, in 2014–2015, 15 FERN Microbiology Cooperative Agreement Program (MCAP)
laboratories, many also funded to obtain laboratory accreditation through the ISO CAP,
participated in FDA’s large-volume surveillance assignment, analyzing imported and domestic
avocados for the presence of Salmonella and L. monocytogenes. Their sample results were used
to establish statistically relevant risk assessments as well as to support FDA regulatory
decisions.
Selected state laboratories that are also members of FERN are the primary servicing laboratory
for their respective state’s regulatory agency that is enrolled in the FDA’s Manufactured Food
Regulatory Program Standards (MFRPS) and/or Animal Feed Regulatory Program Standards
(AFRPS). These two sets of standards are used by the states to guide continuous improvement
in food manufacturing and animal feed programs. Standard #10 of the MFRPS and AFRPS
addresses state laboratory services and their quality management systems. Many of the states
with FERN-supported laboratories that seek to attain laboratory accreditation participate in the
FDA’s Rapid Response Teams, a program created to address the need for improved, integrated,
and rapid responses to food- and feed-related emergencies.
A cooperative agreement with the Association of Public Health Laboratories (APHL), the
Association of Food and Drug Officials (AFDO), and the Association of Animal Feed Control
Officials (AAFCO) has also been established to further regulatory laboratory integration. This
agreement seeks to facilitate long-term improvements in the national food and animal-feed
safety system by strengthening multi-disciplinary laboratory collaboration and equivalency,
thereby advancing laboratory accreditation, and building an integrated community of federal,
state, local, and tribal regulatory laboratories.

5. General Findings
This section summarizes the results of the Subcommittee’s review of: (1) the FERN CAP, and (2)
funding for state laboratories to achieve ISO accreditation. The review includes an assessment
of Public Health Impact (Section 5.1 below), Funding Mechanisms (Section 5.2), and Metrics
(Section 5.3). The report also addresses two areas where the Subcommittee felt that
improvements would increase the effectiveness of FERN: Data Analytics (Section 5.4) and
Training and Workforce Development (Section 5.5).
9

5.1 Public Health Impact
FERN plays a critical role in establishing a national integrated food safety system by increasing
national capability and capacity to detect, prevent, prepare for, respond to, and recover from
threats to the country’s food supply. Because the FERN CAP laboratories bring training assets as
well as provide equipment and personnel, they are able to rapidly respond to these threats to
the food supply. They also provide FDA with increased capacity and capability in fulfilling its
responsibility to respond to such threats. The following sampling of a range of significant
national and international incidents highlight the critical value of the FERN laboratories in
helping maintain a safe food and feed supply.
FERN CAP laboratories were instrumentally important, for example, in the national response to
the melamine adulteration incidents of 2007 and 2008 that affected the safety of the food and
feed supply in China and elsewhere. In the pet-food adulteration incident of 2007, FERN
chemistry laboratories worked with FDA laboratories to develop and validate a screening
method to detect this toxic industrial compound in pet food. The FERN laboratories analyzed
more than 200 samples as part of an FDA assignment to determine the extent of contamination
of the nation’s pet-food supply. The subsequent melamine adulteration incident involving milk
and infant formula products (2008–2009) spurred FERN laboratories to develop two new
methodologies to detect melamine and melamine by-products in milk-containing foods. The
FERN laboratories then analyzed more than 300 samples, providing additional analytical surge
capacity to FDA field laboratories in protecting public health.
In addition, following the 2010 Deepwater Horizon oil spill in the Gulf of Mexico, FERN CAP
laboratories provided much-needed method development and analytical capacity that allowed
a safe reopening of the Gulf waters to commercial fishing. FERN laboratories, along with an FDA
laboratory, developed and validated a new rapid-screening method to detect petroleum
contamination in seafood, decreasing by half the amount of time that previous analytical
methods had required. The FERN laboratories were thus able to rapidly analyze more than 460
samples, making possible more rapid access to the Gulf by the commercial fishing industry.
In 2011, FERN radiological CAP laboratories were activated to respond to the Fukushima, Japan
nuclear disaster. FERN laboratories, in collaboration with the FDA radiological specialty
laboratory, participated in method development and validation; both federal and state sample
testing laboratories used these FERN methods and its equipment for rapid and extensive testing
of suspect products. These FERN accomplishments helped ease the public’s fear of possible
radiological contamination.
Finally, the FDA engaged FERN CAP laboratories to expand the testing capacity to detect arsenic
in juices and rice products in 2012. FERN chemistry laboratories were activated to analyze
backlogged samples, allowing a quicker determination of the extent of arsenic contamination in
these products.
An example of the integration of both the FERN cooperative agreement program and the ISO
accreditation program would be the 2015 nationwide recalls of ice cream products due to L.
10

monocytogenes contamination. These recalls were triggered by the analytical work of
FDA/FERN-ISO-supported laboratories, with the rapid analytical data acceptance facilitated by
the laboratory quality systems being installed with the ISO cooperative agreement funding.

5.2 Funding Mechanisms
The Subcommittee evaluated three existing funding agreements, which were funded in FY15 as
follows: (1) FDA FERN Cooperative Agreement Continuation Program, U18 ($10.1M); (2) ISO/IEC
17025:2005 Accreditation for State Food Testing Laboratories, U18 ($9.3M); and (3) Building an
Integrated Laboratory System to Advance the Safety of Food and Animal Feed, U18, ($1.1M).11
The FERN funding mechanism has existed since FY05, and the other two funding agreements
have been in place since FY12,12 with year-to-year funding levels remaining relatively consistent
over the last eight years (Figure 2).13
$25,000,000
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$15,000,000

$10,000,000

$5,000,000
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Figure 2. FERN Funding Levels 2005–2016

The FERN Cooperative Agreement Program offers funding on a competitive basis to state, local,
tribal, and territorial FERN laboratories to increase analytical capacity and expertise during
events that require surge capacity testing of samples, including the provision of supplies,
personnel, facility/equipment upgrades, training in current testing methodologies, participation
in proficiency testing, participation in method enhancement activities and analysis of
surveillance and emergency outbreak samples.14 In FY15, the FERN CAP provided a total of
$10.1M to 26 awardees15, including 14 chemistry laboratories, 14 microbiology laboratories,
11

Indicative of the funding range, in prior years, this third CAP funding stream had been as high as $1.5M.
In FY15, the three FERN funding streams were consolidated into one.
13 In FY13, federal budget sequestration impacted these three programs, wherein #3 incurred a 50% cut, for example. While
most programs’ funding was eventually restored, some FERN programs have not been restored to pre-sequestration levels.
14 https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-019.html
15 Some laboratories have more than one discipline.
12

11

and 5 radiology laboratories; the period of performance for each award was one year with the
possibility of up to four additional years of funding, depending on performance and continued
availability of federal funds. FDA funding for the FERN CAP has been relatively level (FY12 =
$10.6M; FY13 = $9.5M; and FY14 = $10.1M) but has been limited to current FERN laboratories.
The selection process for the cooperative agreements considered several criteria, including: (1)
current capabilities and capacities of the laboratories; (2) abilities of laboratories to perform
large-scale testing for FERN, if requested to do so; and (3) geographical distribution of selected
laboratories across the nation.16
The ISO/IEC 17025:2005 Accreditation for State Food Testing Laboratories Cooperative
Agreement Program has a $9.3M annual appropriations limit and provides funds to 46 state
food testing laboratories to obtain, maintain, and/or expand laboratory accreditation to
recognized international standards (ISO/IEC 17025:2005). The goal of this ISO-related funding is
to achieve a nationally integrated food safety system that can be further expanded. The
agreement’s purpose is three-fold: (1) conduct food analyses in accordance with the
procedures of an ISO/IEC 17025:2005-accredited laboratory, (2) maintain the accreditation of
presently accredited laboratories and/or expand the scope of ISO to additional sections within
the laboratory, and (3) achieve laboratory conformance with Standard #10 of the Manufactured
Food Regulatory Program Standards (MFRPS). Standard #10 requires that all food testing
performed for the program be done in regulatory laboratories that are accredited in
accordance with ISO/IEC 17025:2005, or are implementing quality systems on par with ISO/IEC
17025:2005. The intended outcome is for microbiological and chemical food analyses
performed on behalf of state manufactured food regulatory programs to be conducted in
compliance with the procedures in an ISO/IEC 17025:2005-accredited laboratory.
The Building an Integrated Laboratory System to Advance the Safety of Food and Animal Feed
Cooperative Agreement Program was established to strengthen multi-disciplinary laboratory
collaboration and equivalency; establish a platform for building an integrated laboratory
community; and advancing the sharing, equivalency and acceptability of laboratory results.17
This CAP, which is limited to national non-profit organizations, guarantees support for one year,
with the possibility of up to four additional years of funding, depending on performance and
continued availability of federal funds. The CAP has an annual budget of $1.5M with a period of
performance from September 2012 through August 2017; and, as of this writing (September
2016), this is the fifth year in which APHL has received this award. APHL is required to subaward a minimum of 25% of the funds received to at least two different associations, one
representing state manufactured food regulatory officials (e.g., Association of Food and Drug
Officials [AFDO]) and the other association must represent state animal feed regulatory officials
(e.g., Association of Animal Feed Control Officials [AAFCO]).
The Subcommittee reviewed the latest available progress reports covering the performance
dates from September 1, 2015, through February 29, 2016, from 24 randomly selected
16
17

The FY15 FERN RFA restricted eligibility to only those laboratories that were receiving funding at the time of application.
http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-025.html
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laboratories provided by the FDA/ORA FERN Program Office. Ten reports represented FERNCAP-funded laboratories; another ten reports represented the ISO/IEC laboratories; while five
reports represented ISO/IEC self-assessment gap-analysis. Budget plans from five state-level
public health or agriculture laboratories that were awarded funds for both chemical and
microbiology preparedness areas were evaluated for consistency of expenditures relative to
expected outcomes. An effort was also made to determine each of the laboratories’ prefunding status prior to September 1, 2015, to evaluate the effectiveness of the program’s ability
to achieve the targeted outcomes. Finally, the Subcommittee reviewed APHL’s March 30, 2016,
interim CAP progress report for Building an Integrated Laboratory System to Advance the Safety
of Food and Animal Feed.
From the review of the progress reports, we made a number of findings.18 Generally, FERN’s
existence expands the FDA’s laboratory-based regulatory capacity as the network
simultaneously serves in the promotion of emergency-related food safety through the sharing
of regulatory data. FERN acts as an additional resource, enhancing FDA’s existing capacity.
Meaningful progress has been made in performance areas such as sample analysis or
surveillance events; method extension or enhancement studies and proficiency testing (PT)
challenges. All the grantees were involved in increased sample analysis or threat-related
surveillance testing; the number of events ranged from one to nine, with an average of four
events per laboratory. Of special note, expenditures for acquiring necessary scientific expertise
comprised the largest budget line item, with the combined chemistry and microbiology
personnel expenses (approximately $144,000/FTE), totalling 50% of the grant, and ranging from
22 to 86% of the total annual award per grantee. On average, grantees reported six FDApurchased and/or loaned equipment/instrumentation acquisitions, directly enhancing the
network’s overall testing capability and capacity. Nine of the reviewed grantees completed 19
method extension/enhancement studies. Furthermore, all laboratories completed two PT
challenges between September 1, 2015, through February 29, 2016, and some completed as
many as four. Historically, since 2004, the FERN PT program has administered 63 separate PT
exercises involving microbiology, chemistry, and radiochemistry.
An FY15 budget review from a cross-section of five (~20%) of the 26 participating state
laboratories revealed funds were used in an efficient manner, supporting expenditures and
activities that contribute to expected outcomes. Pre-assessment gap analyses indicate that
laboratories that were selected to receive funds for ISO/IEC 17025:2005 had well-designed and
high-quality management infrastructure with an enhanced likelihood to achieve ISO/IEC 17025
accreditation. Reports reviewed by the Subcommittee from 19 laboratories revealed that six
were ISO/IEC 17025:2005 accredited, four had completed and submitted their 17025
application, and the remaining nine were on schedule with their respective accreditation action
plan. At present, 18 of 36 awardees (50%) are ISO/IEC 17025:2005 accredited.
18

Unfortunately, APHL’s year-four report was not organized in a standardized manner that would allow the Subcommittee to
report progress across the nine activity areas as defined in the Funding Opportunity Announcement.
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5.3 Metrics
Since its inception, FERN has established and maintained cooperative agreements with state,
local, and tribal public health or agriculture laboratories. The cooperative agreements require
that each funded/grantee laboratory meet criteria regarding staff training, analysts’
proficiencies, method development, testing-sample processing time (i.e., from the time that a
sample is received to the time that testing results are reported), and dissemination of test
results, where possible, across the national network. Continuation of funding, which is
renewable annually for up to five years, is contingent upon the laboratory fulfilling the
expectations set forth in the cooperative agreement.
At the FERN national program level, FDA and USDA-FSIS jointly determine the aggregate need
for capability and capacity to respond to food-related emergencies. Capability (the ability to
accurately perform the laboratory testing set forth in the cooperative agreement) and capacity
(the ability to conduct the number of tests agreed to in the cooperative agreement and in the
time specified) are periodically assessed through exercises. FDA and USDA-FSIS have developed
metrics at the agency level and the national-program level (Appendix D), not all of which have
been included in the cooperative agreements or tracked at an enterprise level.
The Laboratory Response Network (LRN), managed by the CDC, has an analogous mission to
that of the FERN and responds to public health emergencies, especially those involving selected
agents. The Subcommittee agreed that many of the metrics used currently by the LRN could
readily be adapted for use by the FERN. The LRN capability assessment is focused on five
functions:
1)
2)
3)
4)
5)

Managing laboratory activities,
Performing sample management,
Conducting testing and analysis for routine and surge capacity,
Supporting public health investigations, and
Reporting results.

Each function consists of specific tasks, which are assessed by one or more distinct
performance measures. The Association of Public Health Laboratories (APHL) has also
developed an extensive set of metrics for cooperative agreements (Appendix D), some of which
could be adapted by the FDA and FERN.

5.4 Data Analytics
Access to high-quality data collected throughout the food system, as well as the ability to
conduct meaningful statistical analyses on such data, is critically important to implementing an
integrated food safety system. Data analytic tools and infrastructure — including computational
capacity, data storage, and communications capabilities that allow efficient data acquisition,
retrieval, and sharing among laboratories — as well as up-to-date statistical software and staff
competencies, all contribute to timely and efficient utilization of data for risk-based decision14

making. Given the objectives of FERN, it is essential that the network’s data analytics19
functions are working well and seamlessly across all partnering institutions.
The FERN Subcommittee reviewed multiple reports, conducted site visits, and interviewed a
number of collaborative laboratories. Findings include the fact that, today, FERN laboratories
generate data and attempt to transfer data to FDA by email and fax, after which it is generally
re-entered manually into statistical software such as spreadsheets and analysis software. The
Subcommittee believes that the archaic transfer mechanisms and the manual re-entry of data
poses a major risk to data integrity, and is a stumbling block to willingness/ability to share.
Among the many issues that apparently drive this situation is an IT firewall/cybersecurity
concern that is designed to reduce risk of access to FDA data systems and thereby isolate them
from their partners in the FERN network. Because the FDA must use data to serve its regulatory
mission, functions, and actions, the security and integrity of that data is paramount.
Nevertheless, if the basic security concerns preclude a desire and willingness of fully vetted
partners to contribute, it in essence has the ability to cripple the intent of the network.
FDA’s security/integrity concerns, relative to its FERN partners, compromise the adequacy of
data sharing and thus the capacity of the entire system to function efficiently and effectively.
Attempts have been made to develop alternate approaches such as using an FDA-owned
computer located at the partnering association for the data transfer. However, these attempts
have also failed to find a functional process. This matter deserves a high-level policy discussion
and consideration as to how the FDA’s IT system can be changed to also advance the success of
an integrated national foodborne illness prevention and mitigation program. In the end, the
only solution may be to develop a new modern IT infrastructure, built from the ground up with
both adequate security as well as ease of access and use in mind.
Currently, regulatory inspection data also are manually entered into FDA computers from the
FERN network. Double entry results in significant errors and lost time. Implementation of a very
basic file transfer capability, as an interim measure, should be explored to address these
manual entry data risks. The Subcommittee recognizes that a balance must be achieved that
serves data security needs and also preserves some degree of access that is dramatically
improved from the status quo and thus serves the public health needs for mitigating foodrelated illness. Decision making by FDA must be evidence based, and the FERN network should
be recognized as an important part of the foundational knowledge base.
The Subcommittee came to realize through its interviews and observations that the
independence of state laboratories may exacerbate the data-sharing problem; however, this
should be mitigated once a modern IT-infrastructure — delivering security and accessibility — is
incorporated into the FDA system. When FERN is establishing various events for collaboration,
there is a clearly perceived value and appreciation on both the state and FDA laboratory side.
That goodwill is visibly eroded by relegating key data unusable when placing it behind partner19

For the purposes of this report, the Subcommittee defines data analytics as the combined capabilities that facilitate accessing
and sharing relevant data within FERN and completing appropriate computations on the data in a quick and efficient manner.
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inaccessible firewalls.
The eLEXNET presents a theoretical design possibility by allowing a dual construction (i.e.,
having both a firewall-protected FERN functionality and a non-firewall-protected food data
analytics sharing component), and this approach might make sense for FDA. However, the lack
of functionality on the non-firewall side defeats the purpose and may again discourage the use
of eLEXNET. In addition, because eLEXNET is a fairly old IT system, the question arises as to
whether it is more efficient to support the current system or redesign with a modern IT
infrastructure that equally addresses security and access. This may sound simplistic, but
weighing the lessons learned and the newer approaches in database design may point to
greater value in the long-term gains to be realized from redesigning and building anew.
The Subcommittee also considered the IT needs of FSMA and determined that there is a
concern that FSMA needs may be decreasing much-needed attention to FERN. This is yet
another impediment to addressing the complicated FERN resource issues. Regardless of the
competing interests between different FDA functions, managing legacy data is not trivial and
must be taken into account when the IT system is redesigned to achieve serious gains in
functionality. In conclusion, the task of migrating legacy data must be incorporated from the
outset in the planning of any future effort.
Thus, moving data into the FDA/USDA-FSIS system is a technical problem that imposes a burden
on staff time and compromises database quality control. At the center of this challenge is
eLEXNET, an outdated data management system that is currently undergoing updating and
improvements and that is not protected by a cyber-secure firewall. Many laboratory staff,
consequently, do not see a benefit in using this system, largely because, unlike staff of the state
department of health or other relevant state agency, they do not generally need to access this
data that is collected from across the states. Some IT effort, such as the Partnership for Food
Protection (PFP) Information Technology (IT) workgroup, is now being devoted to ameliorate
this barrier to a more seamless transmission of data from the state level into the fire-wallprotected FDA/USDA-FSIS system. It seems clear that any solutions to this data migration
matter will be more successful if their design is driven by the information needs of the users.

5.5 Training and Workforce Development
Optimal response to food emergencies requires that several disparate types of technical,
material, and human resources be in place at all times, and it requires that effective protocols
be established, understood, and carefully followed. For example, laboratories require: (1)
trained and expert staff who have appropriate levels of relevant educational background; (2)
staff access to continuous training and educational opportunities in order to maintain and
increase skills and knowledge; (3) up-to-date equipment and facilities to be able to assist with
analyses and seamlessly and efficiently share data and information within the network, (4)
adequate communication capacity in order to engage other networked laboratories and to
share data and information, as needed; and (5) funding to respond to emergencies as they
arise.
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FERN has a strong focus on training and workforce development among the network of
laboratories that it supports and with which it collaborates. Specifically, training is offered in a
number of areas that have relevance to responding to bioterrorism and infectious disease
outbreaks: detection of radiological, chemical, and microbial agents; detection of select-agents
(e.g., toxins/poisons, disease-causing viruses and bacteria); and rapid-detection methodologies.
The FERN network also has helped develop and promote the use of more up-to-date
technologies for laboratory analyses. This, in turn, results in increasing the capacity of the
workforce in FERN-affiliated laboratories. The network engages its members in laboratory
proficiency testing exercises — as well as quality assurance and auditing training — that help
improve practices across a range of functions and responsibilities of the FERN system.
These activities have supported not only training and development of the existing laboratory
workforce but also the ability to recruit new scientists who are more attracted to working in a
laboratory environment that is more state-of-the-art and operational. Moreover, because the
FERN network makes available electronic communication and collaboration tools, these assets
have the potential to assist personnel across collaborating laboratories in learning how to
utilize and adopt new practices that increase efficiency and accuracy of laboratory functions.
The Subcommittee believes the value of the FERN network for enhancing training is apparent.
The Richmond, Va., laboratory is funded by the USDA-FSIS to serve as a training center for other
laboratories. The Subcommittee visited the Richmond laboratory, which has developed a wellequipped training facility. The Subcommittee learned of several anecdotal examples of state
laboratory scientists who had participated in FERN network training then becoming the de facto
subject-matter experts on those issues within their own states.
The Subcommittee believes that the FERN-enabled training is a valuable way for the federal
government to leverage the personnel in the FERN network to share best practices and to train
personnel across the FERN system. However, while some training efforts are broadly available,
other training efforts only benefit laboratories that are part of the FERN network. Another issue
that needs to be addressed is travel for training. State laboratory representatives with whom
the Subcommittee spoke indicated that most of their staff travel is funded by grants and that
even when there are grants, there are several levels of approval that can create obstacles to
staff access to training. States need both access and funding to participate in training or more
training solutions such as the Richmond laboratory’s creative “training in-the-box” system that
does not require travel.
In terms of workforce development, there are several ways that the FERN network is effective,
and could be more effective. The very process of engaging the FERN network laboratories in
development and deployment of new laboratory technologies, as well as in efforts to boost
staff proficiency in applying laboratory methods and adopting new electronic systems,
indirectly helps to support the professional development of the laboratories’ workforce.
However, the program seems to have reduced the frequency of conferences and other venues
that help to build professional networks that in turn promote continuing development of the
17

scientists in the FERN laboratories. Also the ability to attend professional conferences helps
enable the recruitment and retention of the best scientists.
In addition, the Subcommittee learned of a number of obstacles caused by states’ personnel
processes that were adversely impacting the network’s national capacity to be effective. Some
of these problems include: the inability to offer competitive salaries, excessive staff turnover,
and lack of career mobility for scientists within some state personnel systems. These problems
are not easy to address, but they are solvable.
Specifics concerning FERN’s workforce-related challenges include the fact that salaries are not
sufficiently competitive. Evidence of this relates to staff retention. For example, state
laboratory staff have turned over four times in 12 years. To address this handicap, states would
need to update personnel classifications. To the extent that FDA’s recent efforts to evaluate
salary grades of ORA field staff might have an impact on FERN laboratory staff salaries is not
known.
Another workforce issue concerns professional development, for which there is a large need.
This includes the need to increase opportunities for internships and fellowships. Perhaps FERN
grants could be used to support attendance at conferences, enhance professional
development, and create a learning environment that is attractive to scientists and
characteristic of exchange of scientific discoveries and information (e.g., annual meetings of
scientific societies). The current lack of funding for such has eliminated this important
opportunity for competency development and education. Travel funds that promote
professional development and networking are a part of this need and would contribute
immensely to advancing this valuable component of developing and expanding our scientists’
professional networks. Training in the FERN laboratories, on the other hand, is an impressive
counter to the limitations in professional development opportunities. For example, the trainingin-the-box approach allowed for regional lab staff to join remotely in training exercises where
materials and reagents were shipped to remote locations and virtual training programs using
voice and video connection allowed for remote hands on training. The Subcommittee was
impressed with this creative approach to training.

6. Conclusions
The goal of this report is to ascertain how ORA can advance and establish an effective nationally
integrated laboratory network among ORA, FDA Center laboratories, and state public health
and food- and feed-testing laboratories. Specifically, the Subcommittee was asked to address
five questions; below are the responses to these questions based on the Subcommittee’s
review.

6.1 Promoting and Building an Integrated Laboratory Network
Question 1: How can we further promote and build an integrated laboratory network among the food
regulatory laboratories of ORA, FDA Centers, USDA’s FSIS, and state health departments as part of
developing a stronger system of mutual reliance in the food and feed program?
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An evaluation of the current system including FERN indicates that efforts to date have laid the
groundwork for a stronger, more integrated network of food regulatory laboratories that have
a much greater scientific capacity and function in a more rapid and coordinated fashion in
response to national food safety emergencies. At the same time, the Subcommittee concludes
that there is a need to double down on the effort to strengthen the nation’s food regulatory
laboratory system. The existing network could be made to operate much more effectively and
efficiently if it were possible to overhaul systems for reporting and accessing data. As noted
below, modern computer security systems should be able to embrace secure means of data
transfer that allow for free exchange of data and analyses yet do not compromise computer
systems within federal, state, and local governments. Second, the existing network could be
leveraged to provide a higher level of training and technical support to all food regulatory
laboratories in the nation, not just to those with FERN funding. Third, it is important to consider
expanding the depth and breadth of FERN funding. Laboratories with FERN funding would
benefit from additional resources for training and travel as well as more funding for largesample analytic demands. As noted below, the FDA and the public have benefitted from the
investments in FERN to date. The FDA would benefit from the opportunity to expand the FERN
network by being able to offer FERN grants to more state and local laboratories.
Therefore, the Subcommittee concludes that the FDA has the opportunity to continue to
develop and expand the FERN network. There is a wide range of capabilities and readiness to
respond to food emergencies across FERN laboratories. However, with nearly 170 laboratories
among the FDA, CDC, USDA-FSIS, and states, there are many more laboratories than FDA and
FSIS have funds to support. Therefore, it is important for FDA (and consequently USDA-FSIS) to
critically evaluate how FERN’s limited funds can best be utilized to build a sustainable
integrated laboratory network that meets public health and regulatory needs within an
integrated national food safety system.

6.2 Data Sharing
Question 2: What are the appropriate scientific, analytical, and technical capabilities required to
facilitate the sharing of laboratory data between public health and regulatory agencies in a
timely and efficient manner to enhance consumer protection?
The Subcommittee has identified a number of concerns regarding the lack of well-designed
features as well as poor performance of the existing data-analytics infrastructure.
First, the Subcommittee determined that FERN’s data analytical capability requires an efficient
sharing of the range of data types among multiple network partners. Across FERN laboratories,
the Subcommittee found an extraordinary dependence on the manual transfer of data from
one platform or source to another — even to the point of staff having to resort to using faxes to
share data between laboratories followed by a re-keying of data. This lack of seamless data
transfer is a function of outdated and inadequate infrastructure resources and discrepancies in
technology across laboratories. Needless to say, manual methods of sharing data are prone to
significant errors and are highly inefficient. The Subcommittee discovered that this well19

recognized weakness is often discussed in FERN laboratories and is rooted in fundamental
differences among partners (i.e., CDC, FDA, USDA-FSIS, state laboratories) as to the need for, or
the control of, data access. The fact that this is a long-term systemic problem has only
exacerbated the issue and impacted staff morale and organizational commitment to the value
of the FERN network.
It appears that the regulatory function is driving the IT/supervisory reaction, causing the
creation of an ultra-isolation model that does not have the flexibility to serve other important
FDA functions. FDA should take advantage of other large data-sharing opportunities to create
some unified data designs. Redesign of IT infrastructure should be done within the context of a
long-range strategic planning process as well as within the context of delivering a rapid
implementation of near-term fixes. As a redesign of basic system architecture is being
implemented, IT considerations should focus early on avoiding a design dominated by a firewall
driven exclusively by the regulatory function. Stakeholder engagement should be used in the
planning and redesign processes, and these stakeholders must include the state laboratory
partners.
The Subcommittee is concerned about the level of connectivity within the network and the
ability of state laboratories to participate effectively in the FERN network, including the larger,
better-funded laboratories. If the larger more well-supported FERN laboratories are struggling
in these functional capacities, where can we expect many of the other, smaller, and less-wellsupported laboratories to be? The Subcommittee’s sense is that that they are struggling on a
more intense level.
The Subcommittee believes that a dramatically new approach to data sharing is required. The
need for a data infrastructure that is accessible and efficient is critical to the future value of the
FERN network. The current data infrastructure “system” suffers from a combination of factors
including its poor design, insufficient maintenance, and lack of perceived importance of what
should be considered a vital food safety network that links federal and state partners in
combatting foodborne illness. The need for modernization is serious. With the original FERN
network design having omitted interoperability, all users miss opportunities to leverage data
into good decision making and effective policy. The inability to capture analytical data from
FERN laboratories is, in effect, an impediment to full utilization of the FERN-related cooperative
agreements.
Therefore, the Subcommittee concludes that it is important that FDA modernize its food
safety information architecture to ensure safe and secure transmission of data, even while
encouraging and facilitating efficient data sharing and collaboration across the entire
network of food safety regulatory laboratories.

6.3 Benefits and Limitations to Funding FERN
Question 3: What are the realized benefits and limitations to these FERN Network, laboratory
accreditation, and Laboratory Associations (e.g., APHL, AFDO, AAFCO) cooperative agreements,
and how can we improve upon the current utilization of the results of these agreements?
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The Subcommittee asserts that FDA’s commitment to provide future funding opportunities to
FERN, such as the FERN network, accreditation and laboratory association cooperative
agreements, will be required to sustain and ensure the realization of a fully integrated
multilevel (i.e., federal, state, local, and tribal) food- and feed-testing laboratory network. The
Subcommittee found the following realized benefits and limitations:
FERN’s Realized Benefits


Increased expansion of diagnostic capacity through acquisition of specialized
equipment, instrumentation and technology.



Increased capability through specialized training efforts.



Increased capability through recruitment of scientists/experts.



Increased food-testing capability through method extension and enhancement studies.



Increased implementation of standardized methods, procedures, protocols, and quality
processes aligned to ISO/IEC 17025:2005 improves overall network efficiency and
testing precision.

FERN’s Realized Limitations


Loss of FDA funding would be extremely detrimental to FERN testing capacity and
capability.



Present funding is insufficient to replace/upgrade analytical instrumentation that has
exceeded industry-defined life-span.



When funding is available, the ability to procure equipment easily and in a timely
manner remains an administrative challenge.



The expectation to accommodate unanticipated two- to three-fold increases in testing
(sample) volume without a corresponding budget increase for supplies, reagents, and
labor costs caused an undue financial burden on participating laboratories.

The Subcommittee’s review of the latest-available laboratory progress reports revealed that
FDA-ORA’s oversight of CAP grantees was effective, as reflected by prior and current
achievements and progress to date. However, the Subcommittee also determined that current
funding levels can be insufficient to meet a number of critical operational expectations such as
accommodating increased volumes of incoming sample testing; negotiating cost-effective
service contracts; acquisitioning highly sophisticated diagnostic instrumentation; upgrading IT
support/resources, including data sharing; and recruiting and retaining specialized and trained
laboratory personnel. Generally, FERN CAP laboratories are expected to do more each year but
on a flat budget; in some cases the incoming volume of food-/feed-testing samples has tripled
(e.g., Richmond laboratory) due to FDA’s large-scale surveillance assignments and USDA-FSIS
capacity testing, and doing quality and timely analysis on the ever-increasing number of
samples thus is not sustainable.
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Complicating the sample-volume issue is the inability for long-term planning for analyses by the
CAP laboratories due to the inability of the FDA to provide consistent numbers of surveillance
samples into the FERN CAP laboratories. The CAP laboratories were prepared to participate in
FDA’s large-scale surveillance assignments, but these assignments were abruptly cancelled after
one year. While this can relieve the financial burden imposed by increased sample volume, it
prevents appropriate planning for reagents, equipment and personnel. Recognizing the
unpredictable nature of food emergencies, there needs to be better coordination across the
agencies to ensure proper planning to address the uneven workload and achieve efficient
resource use.
Meanwhile, loss of funding would greatly impact the overall capacity of FERN laboratories.
Short-term impacts of funding reduction would include a negative impact on FERN’s ability to
recruit and retain the highly trained scientists who are crucial for effectively using rapidly
advancing diagnostic methodologies. Such a funding loss also would have an adverse shortterm impact on recruiting and retaining technicians with requisite high-level technical skills
necessary to effectively and safely use complex instrumentation. For example, FERN support
accounts for about one-third of overall funding at the Richmond, Va., laboratory, so, if funding
were reduced, the chemical program could not be sustained. Long-term impacts of funding
reductions would include a negative impact on the U.S. government’s ability to enhance and
sustain the necessary FDA/FERN assets for proactive food-supply threat surveillance, as well as
rapid detection and identification of large-scale food contamination (intentional or accidental).
Among many findings related to FERN funding, the Subcommittee determined that a
foundational level of support that would allow the development of core competencies across
laboratories would be an excellent model, especially if it included a tiered system to support
the development of enhanced laboratory capacity and advanced capabilities. Should such a
system be established, it would be ideal if it could be expanded to allow the creation of
regional/national centers, which could be the top tier of the network and thus house the topof-the-line (i.e., most sophisticated and expensive) instrumentation. The tiered organization
would help avoid any tendency of a network of individual laboratories from collectively
acquiring redundant expensive technical assets/resources.
Therefore, the Subcommittee concludes that FDA’s commitment to provide future funding
opportunities to FERN will be required to sustain and ensure the realization of a fully
integrated multilevel (federal, state, local, tribal) food-testing laboratory network. Such
future funding increases should be to increase the depth and breadth of the program,
meaning both further increases to the capacity of existing laboratories as well as expanding
the numbers of laboratories receiving FERN support. This is an investment that will save
money in terms of reduced public health costs as well as costs to industry.

6.4 Public Health Impact
Question 4: How impactful to public health has this building of an integrated laboratory network
and promotion of our state laboratories been to date? Explore case studies.
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The FERN cooperative agreements have had a multifaceted impact on public health. FDA’s
ability, through the FERN, to respond to an attack on the nation’s food supply, as defined and
mandated by U.S. presidential directives, is greatly facilitated by the funding of the cooperative
agreement laboratories. These CAP laboratories prepare to react to large-scale intentional food
emergencies, to detect, respond to, and assist in recovery from such events. FERN is involved in
surveillance assignments to detect related issues. Such assignments can be associated with
large political events, responses to potential threats, or smaller, more-specific proactive
surveillance of a particular geographic area or food product.
The FERN CAP laboratories have also utilized their abilities to respond to large-scale
unintentional food events and have been involved in every large food event in the United
States since 2006. FERN responses have included the development and validation of rapid
testing methods specific to the requirements of the specific event, providing scarce reagents
and/or standards for testing, and testing capacity. For example, FERN provided rapid
methodologies, reagents, and capacity for the 2006 E coli 0157:H7 outbreak associated with
fresh spinach. FERN was also involved in responding to both melamine contaminations (2007 in
pet foods and 2008/2009 in milk and proteins), the Deepwater Horizon oil spill of 2010, and the
Fukushima Japanese nuclear reactor event of 2011. In these cases, FERN reduced FDA’s
reaction time by working with FDA to provide improved rapid methods and the analytical
capacity and capability to define the scope of the emergency and quickly recover from the
event. The ability of FDA and FERN to promote a rapid recovery also has economic benefits; for
example, the development of rapid testing methods and testing capacity by FDA and FERN
facilitated the reopening of the Gulf waters to commercial fishing after the oil spill in 2010.
Federal funding of FERN, including USDA-FSIS cooperative agreements (FY15 cost of $3.9
million) and FDA cooperative agreements (FY15 cost of $10.1 million), resulted in the following
outcomes:
FDA and USDA-FSIS


Nine proficiency testing events were conducted. More than 240 laboratories
participated and analyzed samples (e.g., ground pork, dried protein concentrate,
mashed potatoes, dog food, apple juice, cheese, and acidified water) for a variety of
analytes.



Annual check sample for the FERN Biosafety Level 3 High Risk Unknown Agent Screening
Procedure for Food was provided to 15 FERN laboratories.



Multi-laboratory validations were performed on five newly developed methods,
including:
o A qualitative screening method for identification of 45 poisons/toxins, and
o A Salmonella rapid screening method.
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Five new Food Defense methods for seven different analytes were evaluated, validated,
and approved by the FERN Methods Coordination Committee and added to the
repository of FERN methods.

FDA


Nine training courses provided to more than 150 FERN laboratorians, including:
o Select Agent training courses,
o Rapid methodologies training courses including real-time polymerase chain
reaction (PCR) methods, and
o Radiological training courses.



Continued funding of the FERN Storeroom, providing reagents, supplies and standards
to FERN laboratories. These reagents/supplies are typically difficult to obtain on an
individual laboratory basis or are kept in bulk in the Storeroom for emergency response.
An example of such reagents is the Clostridium botulinum toxin detection kits used by
both FERN and FDA regulatory laboratories.

USDA-FSIS


Targeted surveillance of USDA-regulated commodities (e.g., ready-to-eat [RTE] and raw
meat and poultry products) at retail via FERN CAP partner laboratories was conducted.
Eleven states tested 793 samples for chemical compounds (toxins, poisons, and heavy
metals), eight states tested 616 microbial samples for selected agents in FSIS products
found at retail locations within their jurisdictions.



Six laboratories participated in an exercise testing samples for a variety of chemical
compounds where the specific contaminant was unknown.



Eight training courses in food testing and food defense methods were completed.
Eighty-five laboratory personnel from state and local food testing laboratories attended
courses covering microbiology and chemistry techniques for food analysis.
o One online course of six modules covering a specific FERN toxin screening
method was produced and hosted on the FERN website and has been used by an
additional 75 laboratory personnel.
o Radiochemistry training for the detection of a specific radionuclide was provided
to three laboratories with a focus on a streamlined method with reduced testing
time.

FERN has also facilitated the coordination and sharing of expertise and essential resources, such
as technical capabilities and analytical instrumentation among the partner laboratories. These
resources can be applied not just at a federal and national level, but brought to bear on local
and state food events. A particular benefit of FERN is its ability to facilitate access within the
network to the various specialized instrumentation and analytical capabilities (i.e., radiological
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toxicological, microbiological, and chemical analyses) that are distributed unevenly across
FERN’s geographically dispersed laboratories. An anecdotal example is portrayed in this
personal communication from a PhD analytical chemist at a FERN chemistry CAP laboratory:
“We are an agriculture lab in small state; our FDA equipment has exponentially
increased our capability and capacity. Right now, over 75% of the equipment in my
laboratory is from FDA FERN CAP. In state fiscal year 2015, we processed in excess of
3,000 samples, which included federal, state, and municipal samples, as well as
samples from research projects on food safety (nanomaterial exposure) and
pollinator decline. The matrices include food, soil/sediment, water, and diverse
consumer products. Over 80% of those 3,000 samples involved direct use of our FDA
equipment (LC-MS, ICP-MS and GC-MS). Because of this capability and the staff
expertise, much of which can be traced to FERN involvement and training, we have
become the go-to lab in the state and the region. In short, FERN equipment and
involvement has become a critical core component to our operations.”20
This ability to coordinate and share resources has a positive impact on public health. For
example, the proficiency testing, methods development, training and surveillance activities
outlined above greatly improve the preparedness and responsiveness of federal, state, local,
territorial and tribal government agencies to food emergencies which, in turn, reduces the
impact of such events on public health. Further, the use of common methods and protocols
increases the likelihood that a problem across the nation or a region will be detected and the
extent of the problem can be assessed more quickly.
It is important to note that FERN could have an even greater public health impact with further
investments. For example, FERN was not designed to conduct proactive nation-wide
surveillance of the food system. However, engaging FERN more proactively in food safety and
foodborne illness surveillance efforts may improve our overall ability to detect, respond to, and
mitigate future events. Similarly, implementing the recommendations of this report (e.g.,
improved data sharing) should also increase FERN’s public health impact. As cited in the next
section, it is important that metrics that can measure the public health benefit of FERN be
developed.
Based on this review, the Subcommittee concludes that FERN has a significant public health
impact, and it is vital to maintaining public health preparedness and response. While it is
impossible to quantify the health and economic benefits to society from FERN, the examples
given in above illustrate the magnitude and breadth of the public health problems that FERN
addresses. Thus, it is important that FDA and USDA-FSIS continue investing in FERN and
consider increasing their support.

6.5 Appropriate Metrics
Question 5: What would be appropriate metrics to measure the effectiveness of these
20

White JC, Vice Director & Chief Analytical Chemist, Connecticut Agricultural Experiment Station.
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integration strategies in promoting a national integrated laboratory system?
The Subcommittee asserts that measuring the effectiveness of both FERN and the national
integrated laboratory system is critical for informing funding decisions as well as protecting
public health. However, it is difficult to determine with great confidence that the current
national network of food emergency response laboratories is sufficient and worth the tens of
millions of dollars invested to date. Choosing metrics that more specifically assess the public
health impact will permit cost-benefit analyses that can show the return on this investment
(See examples of metrics in Appendix D).
The effectiveness of a network of laboratories in many respects is built on the effectiveness of
the individual laboratories that comprise the network. Laboratory quality systems require
evidence of precision, proficiency, reproducibility, accuracy, and documentation. Laboratories
rely on their systems both to ensure reliable results, as well as to investigate errors.
Accreditation to the relevant ISO standard (in this instance, ISO/IEC 17025:2005) ensures that
these quality systems are operating and that the laboratory can provide reliable results for
those methods under the scope of accreditation. Laboratory systems depend on both internal
and external audits to maintain all elements of accreditation.
Network- or national-level metrics could be developed around the requirements used for
individual laboratories under cooperative agreements. Metrics for consideration could include
the ability to report equivalent test results throughout FERN. For example, results reported by
FERN laboratory 'X' would have the identical value and/or meaning and an equivalent time-toresults as results by FERN laboratory 'Y' in another part of country. Tools to assess this metric
could include proficiency testing or exercises to simulate an emergency event. Network-wide
standardization and uniformity of testing protocols/procedures, reagent manufacturing, quality
control/calibration material under the umbrella of a comprehensive QMS, like ISO/IEC: 17025,
could also be used as a measurable metric for accuracy and reproducibility of test results across
FERN.
Therefore, the Subcommittee concludes that metrics are important for understanding the
impact of FERN. ISO accreditation is considered the gold standard and is an important metric
but it is not the only performance metric that should be monitored. FDA and USDA-FSIS in
collaboration with state and local laboratories should be charged with developing a broader
range of metrics that more directly assess public health impacts, functionality of the network
as a system, as well as other goals, such as efficiency.

7. Subcommittee Recommendations
The FERN review Subcommittee, in response to its charge from the Science Board, developed
the following set of recommendations in relation to FERN:
Recommendations
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1. FERN consists of a group of diverse laboratories, and the focus on developing a basic level
of capability/capacity across the network is a worthwhile goal that should be supported by
the federal government. The baseline capabilities/capacities needed are not static and
funding should be adapted to reflect these changing needs.
2. Efforts to build and sustain capabilities/capacities across FERN need consistent, multi-year
funding. FDA should consider additional sources of funding, including cost-sharing or
matching requirements for grant programs and recipients, where appropriate and/or
possible.
3. While all laboratories should strive to improve capabilities, especially as some techniques
become more routine, FDA should develop a plan for FERN that would consider the
advantages of a tiered approach designed to avoid unnecessary duplication, for example, of
expensive instrumentation across the network. Thus, while all laboratories should share a
basic level of functionality, the advanced performance capabilities could be housed
primarily or exclusively in regional/national facilities and/or centers with the training and
equipment to specialize in certain analytical areas of importance to both the state and the
FERN missions, to promote efficient use of existing expertise, equipment, and technical
resources.
4. FERN funding agencies (i.e., FDA/ORA, USDA-FSIS) should continue to improve their
engagement to discuss areas of common interest and combine efforts to improve testing
capacity and capability within and across networks.
5. FDA should develop a technology-management plan to anticipate the eventual replacement
of existing instrument platforms that employ newer and more advanced diagnostic
methodologies. The plan should be developed in collaboration with the designated
specialty laboratories and include: platform selection, acquisition, upgrades/enhancements,
along with corresponding technical training for personnel.
6. FDA should assume a holistic approach to addressing the IT and data-sharing needs of FERN
partners. There is a strong public health need for an integrated information infrastructure
that allows the seamless transmission of data in a secure environment that facilitates rapid
analytics. Simply trying to fix the current system is unlikely to achieve this goal; a new
system is needed. Such efforts must be guided by a comprehensive plan that is developed
through stakeholder engagement (i.e., cooperative laboratories) to meet the needs of an
integrated food and feed safety system.
7. FERN leadership should develop clear objectives and adopt a set of metrics for both
individual laboratories and the network, with appropriate targets and consensus as to what
constitutes success and reflects the objectives.
8. FDA, in collaboration with other federal agencies, should convene an annual conference for
the food safety laboratory network to engage scientists in professional
education/development activities and facilitate the sharing of information.
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9. FERN should have the capacity to support professional travel to conferences and/or for
training and development.
10. FDA and its sister federal agencies (i.e., USDA-FSIS, CDC) should work with states on best
practices for hiring and retaining scientists who are needed to perform this mission-critical
work. Possible collaborators for initiating such efforts include the National Governor’s
Association and/or National Conference on State Legislatures. These organizations may be
able to assist with the identification and/or development of models that can be considered
for adoption by states nationally.
11. FDA should regularly communicate with all eligible laboratories to increase public health
preparedness and participation in FERN training efforts.
The Subcommittee advises that the recommendations of this report be accepted with the
utmost urgency and that our specific recommendations be considered as a means of ensuring
the maintenance of a safe and secure food system. The FERN network represents one of the
best national investments in improving the responsiveness of our combined federal, state, local
and territorial governments; the development of IFSS, and the prevention of foodborne
disease.
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Appendix A: Subcommittee Charge
Request for Proposal to the Science Board to Be Classified by the Advisory Committee
Oversight and Management Staff
The Office of Regulatory Affairs (ORA) is hereby requesting that the Science Board establish a
new subcommittee to evaluate the current investments in: (1) the Food Emergency Response
Network (FERN) cooperative agreement program, and (2) funding for state laboratories to
achieve International Organization for Standardization (ISO) accreditation.
Goal: Ascertain how ORA can advance and establish an effective integrated laboratory network
among ORA, FDA Center, and state public health and food- and feed-testing laboratories. Key
areas of integration would include methods harmonization; data sharing, data quality, and data
reporting; appropriate technical capabilities including IT; the role of proficiency testing and
accreditation; and performance metrics.
Background: The mission of FERN is to integrate the nation’s multilevel food-testing
laboratories to detect, identify, respond to, and recover from a bioterrorism act or public health
emergency/outbreak involving the food supply. FERN, established in 2004 by Presidential
Directive, provides multiple areas of support to member laboratories, including cooperative
agreement funding. Currently, there are 170 laboratory members in FERN, and FDA currently
funds, through cooperative agreements, 34 state laboratories: 14 state chemistry laboratories,
15 microbiological laboratories, and 5 radiological laboratories. These laboratories provide
increased capability and capacity for laboratory sample analyses of food products for the rapid
detection and identification of large-scale food contaminations, intentional or accidental, and
have provided these functions for the FDA in most of the large-scale national food events since
their initial funding.
FDA/ORA has also invested funds to enhance laboratory capacity/capability and to assist state
laboratories in attaining laboratory accreditation to recognized international standards (ISO/IEC
17025:2005). These selected state laboratories are members of FERN and the states are
enrolled in the FDA’s Manufactured Food Regulatory Program Standards (MFRPS), a set of
standards developed by the FDA and selected state program managers that can be used by the
states as a guide for continuous improvement for state food manufacturing programs. MFRPS
Standard #10 addresses state laboratory services and their quality management systems. Many
of the states funded to attain laboratory accreditation also participate in the Food Protection
Rapid Response Teams, a program created to address the need for improved and integrated
rapid responses to food and feed emergencies.
FDA/ORA also funds a cooperative agreement with the Association of Public Health
Laboratories (APHL), the Association of Food and Drug Officials (AFDO), and the Association of
Animal Feed Control Officials (AAFCO) to further regulatory laboratory integration. This
agreement seeks to facilitate long-term improvements to the national food and animal feed
safety system by strengthening multi-disciplinary laboratory collaboration and equivalency,
advance laboratory accreditation, and build an integrated laboratory community of state, local,
and federal regulatory laboratories.
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Scope of Work: The scope of work for this Subcommittee would include the evaluation of these
three existing funding agreements and how these agreements or other approaches can best be
utilized to build an integrated laboratory network among public health food- and feed-testing
laboratories. Specifically, how can the Agency continue to build a sustainable integrated
laboratory network that meets the public health and regulatory needs under an integrated
national food safety system? Also, the technical areas of data sharing, proficiency testing,
method harmonization, quality and reporting of analytical results would be assessed so as to
provide recommendations to facilitate the rapid and efficient interchange of laboratory results
in an integrated laboratory network.
Questions for the Board
1) How can we further promote and build an integrated laboratory network among the
food regulatory laboratories of ORA, FDA Centers, USDA’s FSIS, and state health
departments as part of developing a stronger system of mutual reliance in the food and
feed program?
2) What are the appropriate scientific, analytical, and technical capabilities required to
facilitate the sharing of laboratory data between public health and regulatory agencies
in a timely and efficient manner to enhance consumer protection?
3) What are the realized benefits and limitations to these FERN Network, laboratory
accreditation, and Laboratory Associations (e.g., APHL, AFDO, AAFCO) cooperative
agreements, and how can we improve upon the current utilization of the results of
these agreements?
4) How impactful to public health has this building of an integrated laboratory network and
promotion of our state laboratories been to date? Explore case studies.
6) What would be appropriate metrics to measure the effectiveness of these integration
strategies in promoting a national integrated laboratory system?
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Appendix B: Schedule of Interviews with and Presentations to the
Subcommittee
October 9, 2015, presentation:
APHL/AFDO
Shari Shea
Ron Klein
Nancy Thiex
Yvonne Salfinger
October 23, 2015, presentation:
USDA/FERN
Randy Layton
Ron Blakely
November 17, 2015, presentation:
FDA/ORA Office of Partnerships presentation on cooperative agreements
Erin Woodom-Coleman (FDA)
FDA FERN Overview
Don Burr (FDA)
November 30, 2015, presentation:
FDA eLEXNET Overview
JeanPaul Mivoyel (FDA)
Solomon Tadele (FDA)
Rahsaan Tabb (FDA)
January 11-12, 2016, site visit:
Commonwealth of Virginia, Division of Consolidated Laboratory Services – Richmond
Denise Toney – Director
Angela Fritzinger – Deputy Director
Ed Shaw
Chris Waggener
Shane Wyatt
February 24, 2016, interview:
Maria Ishida, New York Dept. of Agriculture
Andrew Cannons, Florida Dept. of Health
March 2, 2016, interview:
Michael Hydock (Pennsylvania Dept. of Agriculture)
Robyn Atkinson (Utah – Public Health Lab)
Phil Zillinger (Indiana State Dept. of Health)
Judy Lovchik (Indiana State Dept. of Health)
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Appendix C: Questions for Laboratory Site Visits
The FDA Science Board Subcommittee on the Food Emergency Response Laboratory Network
(FERN) has been charged with ascertaining how FDA’s Office of Regulatory Affairs (ORA) can
advance and establish an effective integrated laboratory network among ORA, USDA-FSIS, FDA
Centers, and state public health and food- and feed-testing laboratories. The deliverable for the
Subcommittee is an evaluation/recommendations report that addresses the five objectives
outlined below. For each objective, the Subcommittee identified a series of questions to be
asked of laboratory staff during the site visits.
Objective 1. Evaluate existing cooperative agreements with FSIS, APHL, AFDO, and AAFCO to
further regulatory laboratory integration. Questions to address:
1. Describe the funding sources you receive for regulatory laboratory activities. How much of
what you do is funded by the Federal versus the State governments?
2. Describe your relationships/cooperative agreements with FSIS, APHL, AFDO, and AAFCO.
3. Does each agreement have a distinct ‘scope or task’? Or, do they overlap?
4. Can you describe the specific activities for each of the funding streams?
5. Can you describe some of the benefits since receiving this funding? Specifically, has the
funding assisted you in expanding the scientific capacity of your operation? If so, how?
6. What are the remaining areas needing improvement?
7. Describe your experience and status with your laboratory accreditation process?
8. Do you have recommendations to improve the grant/funding/procurement process?
9. Do you have any suggestions to maximize the use of funds?
10. What services, activities or initiatives would be impacted if funding were no longer
available?
11. Do you feel your experience/perspective is representative of all laboratories in the
network? If not, how do you think it differs?
Objective 2. Identify how the Agency can continue to build a sustainable integrated laboratory
network that meets the public health and regulatory needs under an integrated national food
safety system. Questions to address:
1. Can you describe the network’s configuration and where this laboratory fits in?
2. What are your thoughts regarding strategies to ‘sustain’ the network?
3. How has public health benefited since the creation of the integrated laboratory network?
4. How does the integrated laboratory network extend/expand the Agency's scientific
capacity?
5. What could the Agency be doing to strengthen scientific capacity across the network?
Objective 3. Assess technical areas of data sharing, proficiency testing, method harmonization,
quality and reporting of analytical results. Questions to address:
1. How comfortable are the laboratory staff with the equipment they have?
2. Can the proficiency testing program be improved?
3. Has method harmonization impacted competency assessment of testing personnel?
4. What is the quality of and consistency of reporting of analytical results across the network?
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5. Are the network activities improving these capabilities? Do you have any thoughts about
how to further improve them?
Objective 4. Provide recommendations to facilitate the rapid and efficient interchange of
laboratory results in an integrated laboratory network. Questions to address:
1. What’s the current status of data sharing between FERN laboratories?
2. What’s the current status of data sharing between FERN laboratories and FDA?
3. What are the obstacles?
4. Do you have recommendations for improving the exchange of laboratory results?
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Appendix D: Examples of Metrics Used by FERN and Various Other Laboratory
Organizations

FDA FERN Cooperative Agreement Metrics
1) CAP program metrics that are required by Cooperative Agreement Program guidance (2
Code of Federal Regulations Part200 [2 CFR 200]):
a. Quarterly reports including project information and budget information
b. Final reports
c. Monthly calls with project officers
2) Equipment:
a. Operational status of equipment loaned under the cooperative agreement
b. Are service contracts maintained on all equipment loaned under the cooperative
agreement?
c. Are instruments operational greater than or equal to 90 % of the time?
d. Reporting use/impact of equipment on routine laboratory operations (non-FERNdirected activities) including:
i. Improvement of capacity/throughput for normal laboratory sample analysis
ii. Impact of any expanded capability resulting from provided instrumentation
iii. Use of equipment to support routine state laboratory sample analysis and/or
emergency outbreak sample analysis
3) Participation by CAP laboratories in Proficiency Tests (PT) and check sample programs
a. Laboratories report participation and pass/fail results for proficiency tests that they
participated in during the reporting period
i. PT sample sources: FERN, AOAC, other FDA (non-FERN), LRN, etc.
ii. At this time, there is no minimum requirement for numbers of PTs expected to
be performed during each reporting period
4) Cooperative Agreement-Funded Project Accomplishments
a. Report work/outcomes of any method development or matrix extension projects
conducted under the award and anticipated impact of this work, including
submissions of methods for consideration to become official FERN methods that are
available to all FERN laboratories
b. Report any state-initiated sampling programs conducted and funded through the
award, including specific sample information:
i. Numbers of samples analyzed
ii. Products analyzed
iii. Methods used
iv. Results
v. Provide full analytical worksheet packages as requested
vi. Report any state or FDA regulatory action based on results from these stateinitiated surveillance sampling programs
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5) FDA Directed Sampling:
a. Report numbers of samples analyzed and results of any FDA directed or provided
samples
b. Provide official analytical worksheet data packages to be evaluated for potential FDA
regulatory action based on sample results
c. Track percentages of worksheets that meet FDA Center SME technical review
approval requirements to support regulatory action
d. Document any possible FDA regulatory action based on state data reports
e. Document any issues with data worksheets that may prevent FDA use of that data to
ensure issues are addressed and corrected for future data submissions
6) Responsiveness:
a. What is the measured response time of the CAP laboratory to activations or
requests?
b. Percentage of conference call/meetings attended by CAP laboratory during the
reporting period
c. Did CAP laboratory notify the FERN National Program Office (NPO) if capability or
capacity was down for a significant period of time due to vacancies or equipment
malfunctions?
7) Outreach:
a. CAP laboratories assisting non-funded FERN laboratories with training, sample
analysis, proficiency test preparation, etc.
b. Participation in activities supporting state Rapid Response Team programs
c. Participation in Partnership for Food Protection (PFP) activities:
i. Mutual Reliance Programs
ii. Working groups
d. Participation in FSMA implementation support activities
e. List of publications resulting from FERN supported work
f. List of meeting presentations resulting from FERN supported work

DRAFT FSIS Metrics for FERN CAP Projects
Since the CAP laboratories work mostly on individually proposed projects, the most common
metric used for an individual laboratory in the FSIS CAP program is “completed”/“not
completed.”
Selected measures of laboratory’s acceptable progress in the program:
1) Was the proposed project completed? Was project result published, presented,
submitted as validated method to FERN, FDA, or USDA-FSIS?
2) Did the laboratory increase in capacity or capability and is this reflecting the Laboratory
Database (LabDIR) information on the FERN website (www.fernlab.org)? Example:
Laboratory A increased in capability by verifying it could test for ricin in foods. This
would be reflected in the LabDIR as a new capability.
3) Participation by CAP laboratories in the PT and check sample programs.
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4) Participation by CAP laboratories in the training courses. The numbers of students a
state laboratory has sent to training courses might speak to their increases in
capacity/capability as well.
5) CAP program metrics that are required by Cooperative Agreement Program guidance (2
CFR 200):
a. Quarterly reports, including project information and budget information
b. Final reports
c. Monthly calls with project officers
6) Completion of surveillance samples for food defense analytes. This metric is new for this
year for USDA-FSIS. The goal is at least 250 samples for each USDA-FSIS CAP laboratory.
This metric will be a pass/fail or incomplete “grading,” until it is determined that it
should be measured differently.
7) Capability and Capacity Exercise. USDA-FSIS CAP laboratories have participated in an
exercise to demonstrate either their capacity or capability — as recorded in the LabDIR
— through a functional exercise in which laboratories analyze samples supplied by
USDA-FSIS. In the future, the USDA-FSIS CAP program could track time to reporting,
number correct, number completed, and/or number of different analyses performed.
Metrics that have been used for the FERN program as a whole:
8) The FERN program instituted a tiering program that “grades” FERN participating
laboratories based on the information in the LabDIR system. The tier system scores
individual laboratories’ capabilities in the three testing disciplines (microbiology,
chemistry, and radiochemistry), based on the information they submit to the LabDIR.
Overall scores are compared and laboratories are divided into high, medium, and low
categories in a system that only the FERN National Program Office can see. This system
is useful for quick determination of laboratories’ capabilities in individual disciplines.
9) The FERN program, in general, has tracked the number of training courses offered and
the number of participants from individual laboratories, but no goal numbers have been
established concerning participation by individual laboratories. The numbers of students
a state laboratory, or the number of different laboratories that have sent participants to
training courses might speak to the increase in capacity/capability of the network. The
training program does try to fill all available seats in the offered courses, regardless of
CAP status for the laboratories.
10) Participation by FERN laboratories in the PT and check sample programs are tracked, but
no goal numbers concerning participation in individual events have been established.
The PT program does have its own metric of providing one PT per quarter, alternating
between microbiology and chemistry.
Metrics that have been considered, but not implemented, for the CAP program:
1) Number of new matrices validated by a laboratory for a particular method.
2) Completion of a method validation with submission of the data packet to the FERN
Methods Coordination Committee.
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3) Surveillance samples: 400 per year for tier-level-one laboratories, and 250 per year for
tier-level-two laboratories. Analysis can be microbiology, chemistry, and/or
radiochemistry.
4) Include the ability of CAP laboratories to run USDA-FSIS Microbiology Laboratory
Guidebook (MLG) and Chemistry Laboratory Guidebook (CLG) methods as part of the
LabDIR information on the FERN website. This may increase capacity and capability of
the laboratories as well as provide food safety surge capacity to USDA-FSIS.
5) Include the status of CAP laboratories in terms of testing methods being designated
either “equal to” or “same as” those of USDA-FSIS.
Metrics considered but not implemented:
1) Number of trained analysts for a specific method in a state laboratory (regardless of CAP
status). The program did not have enough resources to train everyone at every
laboratory. Also, the staff turn-over at state laboratories meant this could never be
completed. Some state laboratories just do not participate in the training or are
hindered by state policies from attending training.
2) Correct results reported for PT samples, pass/fail criteria (regardless of CAP
status).States that report incorrect PT results are contacted for follow up. However, no
pass/fail or grading criteria is recording in the system. It was determined that if
laboratories were graded, then laboratories would be less likely to participate, especially
following a failing set. It has also been reported by the states that participating in a
graded program for analytes outside of their accreditation scope would be a hindrance
to their participation. We would much prefer they participate and practice an analysis
that they do not run on a regular basis.
3) Include the ability of CAP laboratories to run FSIS MLG and CLG methods as part of the
LabDIR information in the FERN website. The may increase capacity and capability of the
laboratories as well as provide food safety surge capacity to FSIS.
Metrics no longer used/supported, mainly due to lack of resources:
1) Participation of FERN laboratories, regardless of CAP status, in the Annual Training
Conference with scientific sessions for specific disciplines as well as regional discussion
groups
2) Participation in regional meetings led by the National Program Office and regional
coordinator to increase communication between laboratories on regional basis
3) Participation in desktop exercises through regional coordination that demonstrated
proficiency in responses to an event and FERN activation
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Selected Laboratory Response Network (LRN) Metrics — CAPABILITY 12: Public
Health Laboratory Testing*
Public health laboratory testing is the ability to conduct rapid and conventional
detection, characterization, confirmatory testing, data messaging and reporting,
investigative support, and laboratory networking to address actual or potential
exposure to all-hazards.260 Hazards include chemical, radiological, and biological
agents in multiple matrices that may include clinical samples, food, and environmental
samples (e.g., water, air, and soil).261 This capability supports routine surveillance,
including pre-event262 and post-exposure activities.263
This capability consists of the ability to perform the following functions:
Function 1: Manage laboratory activities
Function 2: Perform sample management
Function 3: Conduct testing and analysis for routine and surge capacity
Function 4: Support public health investigations
Function 5: Report results
Function 1: Manage laboratory activities
Manage and coordinate communications and resource sharing with the jurisdiction’s network
of human, food, veterinary, and environmental testing laboratory efforts in order to respond to
chemical, biological, radiological, nuclear, explosive, and other public health threats. This
function consists of the ability to perform the following task:
Task 1: Exchange information and data with laboratories and laboratory networks
within the jurisdiction. (For additional or supporting detail, see Capability 6: Information
Sharing.)
Performance Measure(s) (this is a partial list)
This function is associated with the following CDC-defined performance measures:
Measure 1: Time for sentinel clinical laboratories to acknowledge receipt of an urgent message
from the CDC Public Health Emergency Preparedness (PHEP)-funded Laboratory
Response Network biological (LRN-B) laboratory

*

Note: This LRN material is necessarily incomplete due to length of the original document and includes only
selected metrics. The complete document is available online (at
https://www.cdc.gov/phpr/capabilities/capability12.pdf) and is thus in the public domain; however, it is used here
with permission. The original superscript reference citation numbers are retained for reference purposes for the
readers’ convenience, but the actual references are not listed because of space limitations in this report of the
FERN Subcommittee.
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Start time: Time CDC PHEP-funded laboratory sends urgent message to first
sentinel clinical laboratory
Intermediate stop time: Time at least 50% of sentinel clinical laboratories
acknowledged receipt of urgent message
Intermediate stop time: Time at least 90% of sentinel clinical laboratories
acknowledged receipt of urgent message
Stop time: Time last sentinel clinical laboratory acknowledged receipt of urgent
message

Planning (P)
P1: (Priority) Written plans must include at a minimum the identification of laboratories
and laboratory networks within the jurisdiction264,265 as well as procedures for
interaction with the following laboratories and groups:
o LRN-B reference laboratories within the jurisdiction
 Support and ensure LRN-B reference laboratory communication with all LRN-B
sentinel and all other LRN-B reference laboratories within the jurisdiction
o Federal laboratory networks and member laboratories within the jurisdiction
 e.g., the Food Emergency Response Network, National Animal Health
Laboratory Network, and the Environmental Response Laboratory Network
P2: (Priority) Written plans must include the following elements:
o Documented procedures for contacting sentinel laboratories in the event of a
public health incident 266
P3: Written plans should include processes and protocols for continuity of operations
(e.g., Continuity of Operations Plan or Annex) for chemical laboratory, radiological
laboratory, biological laboratory and select agents consistent with federal guidelines,
which are updated on an annual basis.267 Continuity of Operations should include not
only the ability to conduct testing on unknown and unusual agents but also routine
testing such as the assurance of newborn screening.268 Plans should address, but are
not limited to the following elements:
o Laboratory maintenance of redundant utilities supplies for testing and support
areas for short-term duration (i.e., 72 hours) in case of localized infrastructure
failure
o Formal or informal agreements in place with other agencies to take over critical
testing
o Staff illness
o Equipment failure
Skills and Training (S)
S1: Laboratory staff should be aware of current national policy and practice. Maintaining
this understanding can be accomplished through sending one chemistry
representative, one radiological representative, and one biological representative
from the jurisdiction to the LRN national meeting. Also, it is recommended if possible,
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but not required, that each LRN Laboratory Director also attend LRN national
meetings.
S2: At least one individual on staff should be capable of coordinating personnel safety and
methods trainings, plans, and guidance, and outreach to sentinel and first responder
communities throughout the jurisdiction. These staff should coordinate biological,
chemical, and radiological activities. Depending on the jurisdiction, these positions
may be filled by one or more individuals with the appropriate experience and training
to perform the duties.
Equipment and Technology (E)
E1: Have or have access to a database of current contact information for identified LRN-B
advanced sentinel laboratories, LRN-B reference laboratories, LRN-R laboratories (if
program funds become available), and LRN-C laboratories in the jurisdiction, as well as
laboratories both inside and outside the jurisdiction that work with the jurisdictional
public health agency.269
Function 2: Perform sample management
Implement LRN-established protocols and procedures where available and applicable [and
other mandatory protocols such as those for the International Air Transport Association (IATA)
and the U.S. Department of Transportation (DOT)] for sample collection, handling, packaging,
processing, transport, receipt, storage, retrieval, and disposal.
Tasks
This function consists of the ability to perform the following tasks:
Task 1: Handle, package, and transport samples following established IATA/DOT and
laboratory-specific protocols.
Task 2: Maintain forensic chain-of-custody throughout the sample-management
process.
Performance Measure(s)
This function is associated with the following CDC-defined performance measures:
Measure 1: Percentage of LRN clinical specimens without any adverse quality assurance events
received at the CDC PHEP-funded LRN-B laboratory for confirmation or rule-out
testing from sentinel clinical laboratories
o Numerator: Number of LRN clinical specimens without any adverse quality
assurance events received at CDC-PHEP-funded laboratory for confirmation or
rule-out testing from sentinel clinical laboratories
o Denominator: Total number of LRN clinical specimens received at CDC PHEPfunded laboratory for confirmation or rule-out testing from sentinel clinical
laboratories
Measure 2: Percentage of LRN non-clinical samples without any adverse quality assurance
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events received at the CDC PHEP-funded LRN-B laboratory for confirmation or
rule-out testing from first responders
o Numerator: Number of LRN non-clinical samples without any adverse quality
assurance events received at CDC PHEP-funded laboratory for confirmation or
rule-out testing from first responders
o Denominator: Total number of LRN non-clinical samples received at CDC PHEPfunded laboratory for confirmation or rule-out testing from first responders
Measure 3: Ability of the CDC PHEP-funded LRN-C laboratories to collect relevant samples for
clinical chemical analysis, packaging, and shipping those samples
o Sample Collection, Packing and Shipping Exercise Results (Pass/Did not pass)
Resource Elements
Note: Jurisdictions must have or have access to the resource elements designated as Priority.
Planning
P1:
Written plans should include procedures and protocols for sample collection, triage,
packaging, shipping, transport, handling, storage and disposal. Sample collection
procedure should address 24/7 contact information and submission criteria.
P2:
Written plans should address transportation security and, at a minimum:270
o LRN-B: Select Agent and Toxin Regulations
o LRN-C: Chemical Hygiene Plan
o LRN-R: Radiation Safety and Security Plan, if program funds become available
P3:

P4:

Written plans should include a protocol for chain of custody. Forensic chain of
custody procedures must meet the minimum evidentiary control procedure
requirements established by federal partners such as the Federal Bureau of
Investigation (e.g., LRN, Integrated Consortium of Laboratory Network).271
Written plans should include procedures in place to maintain sampling and/or
shipping supplies stock, or demonstrate ability to procure or have access to supplies
24/7.272

Skills and Training (this is a partial list, hence the non-continuous numbering)
S1:
(Priority) Laboratory staff responsible for sample management must maintain
certification of laboratory personnel in a shipping and packaging program that meets
national and state requirements (e.g., Sample Collection, Packing and Shipping;
ShipPack).
S4:
Document training on practices for personnel safety while managing samples, with
documentation updated a minimum of once per year, for laboratory personnel.
S5:
Maintain appropriate regulatory requirements, including the following elements:
o A valid Select Agent Registration Number (LRN-B Advanced Reference
laboratories only); Standard Reference laboratories are encouraged, but not
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required, to maintain select agent registration to support broader public health
response
o A valid U.S. Department of Agriculture/Animal and Plant Health Inspection
Service/Veterinary Services shipping permit (LRN-B laboratories only)
o Nuclear Regulatory Commission or state licensing requirements (LRN-R
laboratories only, if program funds become available)
Function 3: Conduct testing and analysis for routine and surge capacity
Perform, or coordinate with the applicable lead agency, testing of chemical, biological,
radiological, nuclear, and explosive samples, utilizing CDC-established protocols and procedures
(e.g., LRN), where available and applicable, to provide detection, characterization and
confirmatory testing to identify public health incidents. This testing may include clinical, food,
and environmental samples.
Tasks
This function consists of the ability to perform the following tasks:
Task 1: Provide LRN-B reference-level testing in clinical, food, and environmental
samples for both rapid and conventional methods.
Task 2: Conduct chemical laboratory testing following LRN-C testing methods.
Task 3: Conduct radiological and nuclear laboratory testing following LRN-R (if program
funds become available) testing methods.
Performance Measure(s) (this is a partial list)
This function is associated with the following CDC-defined performance measures:
Measure 1: Proportion of LRN-C proficiency tests (core methods) successfully passed by CDC
PHEP-funded laboratories
o Numerator: Number of LRN-C core methods successfully proficiency tested by
the CDC PHEP-funded laboratory
o Denominator: Total number of LRN-C core methods for which the CDC PHEPfunded laboratory is qualified to test
Resource Elements
Note: Jurisdictions must have or have access to the resource elements designated as Priority.
Planning
P1:
(Priority) Written plans should include the following considerations for surge
capacity:
o Options to optimize procedures based on regular and surge personnel,
equipment, and facility resources for short-term (e.g., days) and long-term (e.g.,
weeks to months) response efforts
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o Triage policies that address how the laboratory will manage surge testing, which
may include:
 Referral of samples to other jurisdictional laboratories
 Prioritization of testing based upon sample type
 Prioritization of testing based upon risk or threat assessment
 Contingencies to assure newborn screening in a surge situation. Newborn
screening can be assured by memoranda of agreement or contracts with
commercial vendors273
P2:

P3:

P4:
P5:

(Priority) Written plans should include preventative maintenance contracts and
service agreements in place for equipment and instruments utilized in LRN
protocols, procedures, and methods at a minimum. Plans should also include
protocols to ensure that equipment and instruments utilized in LRN protocols,
procedures, and methods have been inspected and/or certified according to
manufacturer’s specifications.
Written plans should include a process that provides guidance for referring
suspicious samples (e.g., from sentinel laboratories or first responders) to an LRN
reference laboratory.
Written plans should include considerations for supply accessibility, including
identifying multiple vendors for critical commercially available reagents/supplies.
Written plans should include processes and procedures to operate at expanded
laboratory capacity for surge events and incidents.

Skills and Training
S1:
(Priority) Laboratories participating in radiological or nuclear testing must attain
LRN-R (if program funds become available) Proficiency Testing Program Qualified
status for all analysis methods transferred by LRN-R through the following:
o Attending LRN–R training, if program funds become available
o Completing the associated laboratory validation exercise, demonstrating
performance and precision according to the minimum standards for each
analytical method.
S2:

S3:
S4:

(Priority) LRN-B reference laboratories must attain competency for LRN-B testing
methods by having the ability to test for all agents/sample types/tests listed in the
high risk environmental sample testing algorithm posted on the secure LRN website.
(Priority) All LRN Laboratories (excluding LRN-B sentinel laboratories) must maintain
the competency to pass LRN proficiency tests.
(Priority) Laboratories participating in chemical testing must attain LRN-C Proficiency
Testing Program Qualified status, through the ability to perform the following:
o Core LRN-C methods testing, for all Level 1 (surge capacity laboratories only) and
Level 2 analysis methods transferred by CDC. Core LRN-C methods are identified
on the LRN website and updated at least annually.
o Validation and qualification of at least one new analysis method per year is
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required.
S5:

S6:
S7:
S8:

S9:

S10:
S11:

Document LRN methods training, with documentation updated a minimum of once
per year, for personnel that regularly perform LRN methods, as well as staff
identified as surge-capacity personnel. Documentation should include training date
and manner of delivery (e.g., formal training or “train the trainer”). Formal training:
CDC courses and CD- or DVD-based courses, with completion verified by a formal
demonstration.
If possible, (but not required) send one chemical, one radiological, and one
biological laboratory representative to meetings focused on technical competencies.
Send at least one chemistry representative from each LRN-C Level 1 surge laboratory
to participate in the bi-annual LRN-C Level 1 surge capacity meeting.
Document safety training, with documentation updated a minimum of once per
year, for personnel that regularly perform LRN testing, as well as staff identified as
surge-capacity personnel. Documentation should include training date and manner
of delivery (e.g., formal training or “train the trainer”). Formal training: CDC courses
and CD- or DVD-based courses, with completion verified by a formal demonstration.
Attain accreditation for LRN-C clinical testing, at a minimum, via an appropriate
accreditation body [e.g., at a minimum, Clinical Laboratory Improvement
Amendments (CLIA), or College of American pathologists (CAP)]
Attain accreditation for LRN-B clinical testing, at a minimum, via an appropriate
accreditation body (e.g., at a minimum, CLIA or CAP)
Attain accreditation for LRN-R clinical testing, at a minimum, via an appropriate
accreditation body, if program funds become available (e.g., at a minimum, CLIA or
CAP)

Equipment and Technology
E1:
Have or have access to a biosafety level 3 laboratory.
E2:
Laboratory owns and maintains at least one instrument each for rapid nucleic-acid
detection and antigen-based detection and instruments are listed in the current
equipment list (which is updated annually on the secure LRN website).
E3:
Level 2 laboratories own and maintain equipment for at least one instrument each
for detection of LRN-C agents, that are listed in the current equipment list (which is
updated annually on the secure LRN website), to demonstrate qualified status for
the listed Level 1 (surge capacity laboratories only) and Level 2 methods.
E4:
Level 1 laboratories must obtain and maintain additional support equipment and
supplies listed in each method.
E5:
LRN-R laboratories (if program funds become available) own and maintain
equipment and maintain staff for at least one instrument each for detection of LRNR agents that are listed in the LRN-R Equipment List (which is updated annually on
the secure LRN website).
E6:
Maintain inventory or reliable sources of testing material that includes CDC/LRN
provided analyte-specific test kits, ancillary reagents, control strains, calibration
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E7:

standards, and laboratory supplies required to run LRN analytical methods.
Have or have access to equipment necessary for performing LRN assays.

Function 4: Support public health investigations
Provide analytical and investigative support to epidemiologists, healthcare providers, law
enforcement, environmental health, food safety, and poison control efforts to help determine
cause and origin of, and definitively characterize, a public health incident.
Tasks
This function consists of the ability to perform the following tasks:
Task 1: Establish and maintain the ability to provide analytical support for investigations
with first responders and other health investigation community partners. (For
additional or supporting detail, see Capability 13: Public Health Surveillance and
Epidemiological Investigation.)
Task 2: Provide investigative consultation and technical assistance to jurisdictional
health departments, first responders, and other health investigation community
partners regarding sample collection, management, and safety. (For additional or
supporting detail, see Capability 13: Public Health Surveillance and
Epidemiological Investigation.)
Performance Measure(s) (this is a partial list)
This function is associated with the following CDC-defined performance measures:
Measure 1: Time to complete notification between CDC, on-call laboratorian, and on-call
epidemiologist
o Start time: Date and time that CDC Department of Emergency Operations
official began notification of on-call laboratorian
o Stop time: Date and time on-call epidemiologist (after receiving notification
from on-call laboratorian) notifies CDC Department of Emergency Operations
that notification drill is complete
Resource Elements (this is a partial list)
Note: Jurisdictions must have or have access to the resource elements designated as Priority.
Planning (this is a partial list)
P1:
Written plans should include processes to coordinate activities, gain assistance from,
and/or share data with the following group:
o Epidemiologists who are at the interface between clinicians/hospitals, health
departments, and the laboratory (For additional or supporting detail, see
Capability 13: Public Health Surveillance and Epidemiological Investigation.)
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o Veterinary diagnostic or food safety laboratories, if applicable, which serve
animal populations and investigate food products (For additional or supporting
detail, see Capability 13: Public Health Surveillance and Epidemiological
Investigation.)
Function 5: Report results
Provide notification of laboratory results and send laboratory data to public health officials,
healthcare providers, and other institutions, agencies, or persons as permitted by all applicable
laws, rules, and regulations.
Tasks (this is a partial list)
This function consists of the ability to perform the following tasks:
Task 1: Notify appropriate public health, public safety, and law enforcement officials
(24/7) of presumptive and/or confirmed laboratory results from clinical, food, or
environmental samples that involve a chemical, radiological, or biological threat
agent. (For additional or supporting detail, see Capability 6: Information Sharing.)
Performance Measure(s)
At present this function is associated with the following CDC-defined performance measures:
Measure 1: Time for CDC PHEP-funded laboratory to notify public health partners of
significant276 laboratory results
o Start time: Time CDC PHEP-funded laboratory obtains a significant laboratory
result
o Stop time: Time CDC PHEP-funded laboratory completes notification of public
health partners of significant laboratory results (i.e., time when last public
health partner was notified, if partners were not notified simultaneously)
Resource Elements (this is a partial list)
Planning
P1: Written plans should include processes and protocols to ensure proper security and
maintenance of records management system.277,278 (For additional or supporting detail,
see Capability 6: Information Sharing.)
P2: Written plans should include data-exchange processes, as permitted by all applicable
laws, rules and regulations, with law enforcement, public safety, and other agencies
with roles in responding to public health threats. These processes should address data
security and inappropriate disclosure of information.279,280,281 (For additional or
supporting detail, see Capability 6: Information Sharing.)
P3: Written plans should include notification procedures that detail the process of reporting
results that are suggestive of an outbreak or exposure to appropriate health
investigation partners utilizing secure contact methods per the LRN-B, LRN-C, or LRN-R
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(if program funds become available) Notification Policy and/or laboratory-specific
policies.282 (For additional or supporting detail, see Capability 3: Emergency Operations
Coordination and Capability 6: Information Sharing.)
Equipment and Technology
E1: (Priority) Each LRN laboratory will build or acquire and configure a jurisdictional
Laboratory Information Management System (LIMS) with the ability to send testing data
to CDC according to CDC-defined standards. (This will reduce the duplicate entry into
multiple data exchange systems (i.e., having to put data into results messenger or other
data exchange systems to be able to send to CDC, public health partners, and other
submitters).283,284
E2: Ensure at least one member of each laboratory area represented in the jurisdiction
(LRN-B, LRN-C, LRN-R, if program funds become available) has a working digital
certificate for access to electronic results-reporting systems.
E3: Have or have access to at least one working computer for access to LRN and partner
electronic reporting systems.
E4: Have or have access to a mechanism (e.g., automated, electronic, or paper) for
reporting results to LRN-B, LRN-C and LRN-R (if program funds become available), at a
minimum, as appropriate.285

47

Associations (APHL, AFDO, AAFCO) Cooperative Agreement Draft Metrics (3/16/16)
AIM/activity
being measured
Section # 1
1
1.2- Online
resource
repository

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

Grant

Awareness of
APHL
Accreditation
Resources
website

APHL

Count from website
Accreditation Resources
(http://www.aphl.org/aphlprog
rams/food/laboratoryaccrediation/Pages/Accreditati
on-Resources.aspx)

Yes

With
required
reports to
FDA

Maintain or
increase in # of
views of
accreditation
resources website

Awareness of
Accreditation
Resource
Repository
Active work by
the Associations
to ensure
updated
resources

APHL

Count from website:
Resources for Governmental
Food and Animal Feed
Laboratories
Count from website for
Accreditation Resources and
Resources for Governmental
Food and Animal Feed
Laboratories

Yes

With
required
reports to
FDA
With
required
reports to
FDA

Maintain or
increase in # of
views of resource
repository

2

1.2- Online
resource
repository

Grant

3

1.2- Online
resource
repository

Grant

4

1.3Accreditation
discussion board

Grant

Use of
Discussion
Board

APHL

Count from Discussion Board
SharePoint site: Count #
Topics/Unique threads

Yes

With
required
reports to
FDA

Grant

Active work by
the Associations
to complete
Guidance on
Obtaining

AAFCO

Status of GOODSamples
(completed)

Yes

Status
report:Y03
completion
of

Section #2
5
2.1- Sampling
and sample
handling
guidelines

APHL

Yes

# of new/updated
documents added
to resource
webpage and
repository
annually.
Maintain or
increase in # of
topics/ unique
threads on APHL
Discussion Board
GOODSamples
completed.
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AIM/activity
being measured

Grant or What is being
Impact? measured?

6

2.1 Sampling
and sample
handling
guidelines

Grant

7

2.1- Sampling
and sample
handling
awareness
training

Grant

8

2.1- Sampling
and sample
handling

Impact

Defensible
Samples
(GOODSamples)
Active work by
the Associations
to market
GOODSamples

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

GOODSam
ples
AAFCO

Marketing activities via APHL,
AFDO, and AAFCO

Yes

Marketing
activities
with
reports to
FDA

Providing
awareness
training on the
principles of
defensible
sampling and
Theory of
Sampling (TOS)

AAFCO

Listing of seminars, dates and
venues of awareness training on
the principles of defensible
sampling and Theory of
Sampling (TOS)

Yes

With
reports to
FDA

Adoption of
sampling
practices based
upon
GoodSamples

survey

Survey assessing use of
GOODSamples and subsequent
changes in practice
(would be nice to have baseline
practices, but can still assess
changes/improvements in
practice via self-reporting)

No

Annual

GOODSamples will
be available and
marketed through
Association
websites,
newsletters, email
and similarvenues.
Laboratory
managers and
regulatory program
staff will be aware
of a shift in
paradigm for
sample collection,
TOS and the GOOD
Samples document.
GOODSamples
practices are
incorporated into
regulatory
programs which
participated in
Pilots.
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AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

9

2.2- Web-based
Subject Matter
Expert (SME)
registry

Grant

Convening and
maintaining a
web-based SME
registry

AFDO

Counts from websitehttp://www.afdo.org/sme

Yes

Annual

10

2.2- Web-based
Subject Matter
Expert (SME)
registry

Impact

Value of SME
registry

AFDO
research

Survey of SMEs and
laboratories/programs
www.afdo.org/sme
(specifically Food Laboratory,
Laboratory Accreditation, Pet
Food Testing, Sampling
categories)

No

# registered SMEs
annually by area of
expertise; # of
website hits on
SME database.
SME contacts
resulting in
assistance to a
program or
laboratory

Grant

# of eLEXNET
users running
reports

FDA

FDA as part of CAP

Yes

Increase in number
of users running
reports in eLEXNET

Grant

Availability of a
common set of
data elements
and messaging
standards

APHL, FDA

APHL developed product

Yes

With
required
reports to
FDA
One time

Grant

# of laboratories
adopting a

APHL, FDA

Section #3
3.1- Marketing
11 and outreach
efforts around
eLEXNET
12 3.3- Standard
data elements.
Identify existing
vocabulary and
data messaging
standards and
develop
standards
specific to food
and feed-testing
laboratory
reporting
13 3.3- Standard
data elements.

Availability of a
common set of data
elements and
messaging
standards

Increase in the # of
laboratories
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AIM/activity
being measured

14

Identify existing
vocabulary and
data messaging
standards and
develop
standards
specific to food
and feed-testing
laboratory
reporting
Overall aim of
data sharing

Section #4
15 4.5- Community
building and
networking

16

4.5 Community
building and
networking

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

common set of
data elements
and messaging
standards

Measure of
Success
adopting a
common set of
data elements and
messaging
standards

Impact

Action taken
based on data in
eLEXNET
accredited
scopes

FDA and/or
State
Regulators
(AFDO)

Anecdotal information from FDA
or AFDO members

No

Grant

Active work by
the Associations
to ensure
updated
resources in
Topical Index
for Laws and
Guidance
Awareness of
Topical Index
for Laws and
Guidance

AFDO

Counts of #documents related
to laboratory, laboratory
accreditation, and sampling on
Topical Index for Laws and
Guidance from websitehttp://ti.afdo.org/

Yes

Annual

# of new/updated
documents related
to laboratory,
laboratory
accreditation, and
sampling in Topical
Index.

AFDO

Count of number of views of
documents related to
laboratory, laboratory
accreditation and sampling on
Topical Index for Laws and
Guidance.

Yes

Annual

Maintain or
increase # of views
of documents in
the Topical Index
for Laws and
Guidance.

Grant

Action taken based
on data in eLEXNET
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AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

17

4.6 Standardized
training and
competency for
governmental
food and feed
testing
personnel

Grant

AFDO

Status of competency-based
curriculum framework.

Yes

Annual

Progress within
agreed upon
deliverables of
subcontract with
IFPTI; Ultimately,
completed
competency-based
curriculum for
Governmental
Food and Feed
Testing Personnel

18

4.6 Standardized
training and
competency for
governmental
food and feed
testing
personnel

Grant

Active work by
the Associations
to finalize the
IFPTI
competencybased
curriculum
framework for
Governmental
Food and Feed
Testing
Laboratory
Personnel
Providing
awareness
training of the
Governmental
Food and Feed
Laboratory
Curriculum

AFDO

Listing of seminars, dates, and
venues of the Governmental
Food and Feed Laboratry
Curriculum Framework

Yes

With
reports to
FDA

19

4.6Standardized
Training and
competency for
governmental
food and feed
testing
personnel

Impact

Adoption of the
Governmental
Food and Feed
Laboratory
Curriculum to
create new
training

AFDO
survey—
Future Data
Collection

Survey assessing use of
Laboratory Curriculum and
subsequent changes in practice
(would be nice to have baseline
practices, but can still assess
changes/improvements in
practice via self-reporting)

No

Pending
completion

Laboratory
managers will be
aware of the
Governmental
Food and Feed
Laboratory
Curriculum
Framework
Training
1. Creation of new
training based on
Governmental
Food and Feed
Laboratory
Curriculum
Framework; and
2. State food and
feed testing
52

AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success
personnel are
creating learning
plans and basing
staff training needs
on Governmental
Food and Feed
Laboratory
Curriculum.

Section #5
20 5 (5.1, 5.2, 5.3,
5.4, 5.5)Providing
forums and
improving
communication
and
collaboration

21

5 (5.1, 5.2, 5.3,
5.4, 5.5)Providing
forums and
improving
communication
and
collaboration

Grant

Impact

Active work by
the Associations
to provide
forums ,
committee
meetings and
member travel,
etc.,for
improved
communication
and
collaboration
Value of forums,
committee
meetings and
member travel,
etc., for
improved
communication
and
collaboration

APHL
AAFCO
AFDO

Counts from each organization

Yes

APHL
AAFCO
AFDO
survey and
success
stories

Anecdotal stories and/or blog
posts, etc., following scientific
meetings and conferences;
survey to provide answer to
question “Do you think that
your communication with other
laboratories/regulatory partners
is improved since the CAP”?

No

With
required
reports to
FDA

Total # of
events/committees
and
meetings/other
events attended

Communication
and collaboration
has improved since
the CAP

Section #6
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AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

22

6.2- Educational
opportunities

Grant

APHL
AAFCO
AFDO

Count from each organization

Yes

With
required
reports to
FDA

Increase in
#trainings available
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6.2Educational
opportunities

Grant

Active work by
the Associations
to provide
trainings to
laboratories
seeking/
maintaining
accreditation
Awareness of
pre-recorded
webinars

APHL

Yes

With
required
reports to
FDA

Increase in # of
registrations for
webinars

24

6.2- Educational
opportunities

Impact

Evidence of
applied learning
(e.g., webinars/
seminars

APHL
training
evaluations

Count # of registrations for
webinars from website for
individual webinars
http://www.aphl.org/aphlprogr
ams/food/laboratoryaccrediation/Pages/TrainingResources.aspx
Follow-up survey to send to
webinar registrants

No

Annual

Participants used/
applied webinar
knowledge

Grant

Completion of
Revised AAFCO
Quality
Assurance
Quality Control
Guidelines

AAFCO

Status of the AAFCO Quality
Assurance Quality Control
Guidelines (completed)

Yes

One time
in Y02 for
completion
of the
AAFCO
Quality
Assurance
Quality
Control
Guidelines

A revised version of
AAFCO’s Quality
Assurance Quality
Control Guidelines
completed.

Section #7
25

8.2- AAFCO
Quality
Assurance
Quality Control
Guidelines

54

AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

26

8.2- AAFCO
Quality
Assurance
Quality Control
Guidelines

Grant

AAFCO

Provision of sales #s of
publication;
# of sales of the publication, list
of marketing activities

Yes

27

8.2- AAFCO
Quality
Assurance
Quality Control
Guidelines

Impact

survey

No

One time
(Y04 or
Y05)

28

8.1- Proficiency
testing program
for laboratories
testing animal
feed

Grant

Survey assessing use of revised
guidelines and subsequent
changes in practice
(would be nice to have baseline
practices, but can still assess
changes/improvements in
practice via self-reporting)
Status of accreditation to ISO
17043 of the PT program for
animal feed.

Yes

Annual

3rd party
accreditation to ISO
17043 received.

29

8.1- Proficiency
testing program
for laboratories
testing animal
feed

Grant

Status of roll out of new
programs

Yes

Annual

New analyte(s)
added annually.

30

8.1- Proficiency
testing program
for laboratories
testing animal
feed

Impact

Awareness of
Revised AAFCO
Quality
Assurance
Quality Control
Guidelines
Implementation
and Usage of
Revised AAFCO
Quality
Assurance
Quality Control
Guidelines
Active work by
the Associations
to achieve ISO
17043
Accreditation of
PT program for
animal feed
Active work by
the Associations
to expand the
PT programs for
Feed
Laboratories

AAFCO

AAFCO

AAFCO

No

Reporting
Frequency

Measure of
Success
QA guidelines will
be available and
marketed through
Associations
website, emails and
other such venues.
Change in QA/QC
practices as a result
of revised
guidelines

PT Program is selfsupporting
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31

32

33

AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

8.1- Proficiency
testing program
for laboratories
testing animal
feed

Grant

Active work by
the Associations
to ensure use of
PT programs by
Feed
Laboratories

AAFCO

Count from PT provider

Yes

Annual

Maintain/increase
in # of laboratories
enrolling in and
completing PT.

Success of the
FDA ISO
Cooperative
Agreement
funding to help
laboratories
achieve or
expand their
scope of their
accreditation
Successful use
of state
laboratory data

FDA/survey
by
Assocations

Specific stories through survey
of laboratories- would obtain
text/stories

No

Specific successes
outlining how the
FDA ISO CoAg has
helped with
seeking,
maintaining,
expanding scope of
accreditation

FDA/survey
by
Associations

FDA to provide (Districts or OP?)
or through survey.

No

Increase in
 # of labs
submitting data
packets
 # of data
packets being
submitted
 % of data
packets being
accepted for
regulatory
action by FDA

Overarching ISO measures
FDA ISO
Impact
Cooperative
AgreementAccreditation

FDA ISO
Cooperative
AgreementData acceptance
(FDA)

Impact
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34

35

36

37

AIM/activity
being measured

Grant or What is being
Impact? measured?

FDA ISO
Cooperative
AgreementData acceptance
(Intra/interstate)
FDA ISO
Cooperative
AgreementData acceptance
FDA ISO
Cooperative
AgreementAccreditation

Impact

Impact

Overall aim of
working towards
accreditation

Impact

Impact

Who

How will it be measured?

Already
doable?

Successful state- AFDO
specific
research
regulatory
action

Survey to AFDO’s members for
specific stories of data used for
state-specific regulatory action

No

Successful use
of state data for
import alerts
issued
Success of the
FDA
Cooperative
Agreement
funding to help
laboratories
achieve or
expand the
scope of their
accreditation?
Success of the
FDA ISO
Cooperative
Agreement
funding to help
laboratories
achieve or
expand the
scope of their
accreditation

FDA/survey
by
Associations

Counts

No

FDA/survey
by
Associations

Counts

No

FDA/survey
by
Associations

Counts

No

Reporting
Frequency

Measure of
Success
Use of statespecific laboratory
data for interstate/
intrastate for
regulatory action
Increase in # of
import alerts issued

Increase in # of
laboratories that
achieve or expand
the scope of their
ISO accreditation.

Annual

Increase in the # of
laboratories with a
quality manual.
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AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

38

Overall aim of
working towards
accreditation

Impact

FDA/suvey
by
Associations

Counts

No

Annual

Increase in # of
laboratories with a
full-time Quality
Mangaer

39

Overall aim of
working towards
accreditation

Impact

FDA/suvey
by
Associations

Counts

No

Annual

Increase in # of
laboratories who
have chosen an
Accrediting Body

40

Overall aim of
working towards
accreditation

Impact

FDA /survey
by
Associations

Counts

No

Annual

Increase in # of
laboratories who
have conducted an
internal audit.

Success of the
FDA ISO
Cooperative
Agreement
funding to help
laboratories
achieve or
expand the
scope of their
accreditation
Success of the
FDA ISO
Cooperative
Agreement
funding to help
laboratories
achieve or
expand the
scope of their
accreditation
Success of the
FDA ISO
Cooperative
Agreement
funding to help
laboratories
achieve or
expand the
scope of their
accreditation
internal audits
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AIM/activity
being measured

Grant or What is being
Impact? measured?

Who

How will it be measured?

Already
doable?

Reporting
Frequency

Measure of
Success

41

Aim #1: Support
programs

Impact

survey by
Associations

APHL as part of Yvonne
Salfinger’s contract deliverables

No

Annual

Increase in # of
unfunded
laboratories that
achieved
accreditation

42

Aim #1: Support
programs

Impact

Survey by
Associations

Survey value of different
components (e.g., website,
documents, meetings, webinars,
SMEs)

No

Annual

Specific success
stories on how the
accreditation
resources offered
by Associations
helped laboratories
achieve/enhance
accreditation

Value of
Associations
Cooperative
Agreement on
unfunded
laboratories
Value of the
resources
provided by the
Associations to
help
laboratories
achieve/enhanc
e accreditation
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